Processing 00000000.tx.1: Selective impairment of p53-mediated cell death in fibroblasts from sporadic Alzheimer's disease patients Daniela Uberti1, Teresina Carsana1, Enza Bernardi1, Luigi Rodella1, Piergiovanni Grigolato2, Cristina Lanni3, Marco Racchi3, Stefano Govoni3 and Maurizio Memo1,* 1 Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy 2 Department of Pathology, University of Brescia, Brescia, Italy 3 Department of Experimental and Applied Pharmacology, University of Pavia, Pavia, Italy * Author for correspondence (e-mail: memo{at}med.unibs.it ) Accepted 16 May 2002  Summary Top Summary Introduction Materials and Methods Results Discussion References  In this study, we evaluated the response of different human skin fibroblast cultures obtained from eight probable Alzheimer's disease patients and eight non-Alzheimer's disease subjects to an acute oxidative injury elicited by H2O2. 

Phrase: "Selective impairment of p53-mediated cell death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "from sporadic Alzheimer's disease patients Daniela Uberti1,"

Phrase: "Teresina Carsana1,"

Phrase: "Enza Bernardi1,"

Phrase: "Luigi Rodella1,"

Phrase: "Piergiovanni Grigolato2,"

Phrase: "Cristina Lanni3,"

Phrase: "Marco Racchi3,"

Phrase: "Stefano Govoni3"

Phrase: "and"

Phrase: "Maurizio Memo1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1422348:MEMO1 [Gene or Genome]
   861   C1832610:MEMO1 [Gene or Genome]

Phrase: "* 1 Department of Biomedical Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biotechnologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005574:Biotechnologies [Biomedical Occupation or Discipline]

Phrase: "University of Brescia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Brescia,"

Phrase: "Italy 2 Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587487:Pathology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "University of Brescia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Brescia,"

Phrase: "Italy 3 Department of Experimental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Applied Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0031330:Pharmacology [Biomedical Occupation or Discipline]
   861   C1524059:pharmacology [Functional Concept]
   789 E C0205464:Pharmacologic [Functional Concept]

Phrase: "University of Pavia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Pavia,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "* Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "memo{at}med.unibs.it )"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "16 May 2002  Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the response of different human skin fibroblast cultures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0312646:skin response [Laboratory or Test Result]
   767   C1286259:Skin response [Clinical Attribute]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "obtained from eight probable Alzheimer's disease patients"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0033204:Probable [Quantitative Concept]
   748   C0205454:Eight [Quantitative Concept]
   748   C0332148:Probable [Qualitative Concept]
   748   C1301820:Obtained [Functional Concept]
   728   C0277564:Acquired disease [Disease or Syndrome]
   714 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "eight non-Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   812   C1518422:Non [Functional Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "subjects to an acute oxidative injury"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0205178:acute [Temporal Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C0681850:Subject [Group]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]
   753   C3263722:Injury [Injury or Poisoning]
   753   C3263723:Injury [Injury or Poisoning]

Phrase: "elicited by H2O2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0449265:Elicited by [Qualitative Concept]
           elicited
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.2: This treatment generates reactive oxygen species, which are responsible for DNA damage and apoptosis. 

Phrase: "This treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "generates"

Phrase: "reactive oxygen species,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "which"

Phrase: "are"

Phrase: "responsible for DNA damage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.3: To compare the sensitivity of fibroblasts from Alzheimer's disease or non-Alzheimer's disease patients to H2O2 exposure, we evaluated different parameters, including cell viability, the extension of DNA damage and the ability of the cells to arrest proliferation and to activate an apoptotic program. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the sensitivity of fibroblasts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "from Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "non-Alzheimer's disease patients to H2O2 exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1829939:{Non-patient} [Clinical Attribute]
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "different parameters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cell viability,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "the extension of DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "and"

Phrase: "the ability of the cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an apoptotic program."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159821:apoptotic program [Cell Function]
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.4: We found that fibroblasts from Alzheimer's disease patients were more resistant that those from control subjects to H2O2 treatment, although the extent of DNA damage induced by the oxidative injury was similar in both experimental groups. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that fibroblasts from Alzheimer's disease patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "more resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332325:Resistant [Functional Concept]
   861   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "that"

Phrase: "those from control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "to H2O2 treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "although"

Phrase: "the extent of DNA damage induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439792:Extent [Spatial Concept]

Phrase: "by the oxidative injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "similar in both experimental groups."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.5: The protective mechanism of Alzheimer's disease fibroblasts was related to an impairment of H2O2-induced cell cycle arrest and characterized by an accelerated re-entry into the cell cycle and a diminished induction of apoptosis. 

Phrase: "The protective mechanism of Alzheimer's disease fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "was"

Phrase: "related to an impairment of H2O2-induced cell cycle arrest"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   782   C1155873:Cell Cycle Arrest [Cell Function]
   782   C1516332:Cell Cycle Arrest [Cell Function]
   760   C0007586:Cell Cycle [Cell Function]
   760   C1155839:Cell Cycle [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0205263:Induced [Functional Concept]
   739   C0237477:Arrest [Temporal Concept]
   739   C0392351:arrest [Governmental or Regulatory Activity]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0684336:Impairment [Pathologic Function]
   739   C1269647:Cell [Cell]
   739   C1511572:Cycle [Temporal Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "characterized by an accelerated re-entry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0521110:Accelerated [Functional Concept]
   753   C1705654:Entry [Intellectual Product]
   753   C1880022:Characterized [Activity]
   753   C2986904:RE [Idea or Concept]

Phrase: "into the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "a diminished induction of apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.6: Fibroblasts from Alzheimer's disease patients also have a profound impairment in the H2O2-activated, p53-dependent pathway, which results in a lack of activation of p53 or p53-target genes, including p21, GADD45 and bax. 

Phrase: "Fibroblasts from Alzheimer's disease patients also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016030:Fibroblasts [Cell]

Phrase: "have"

Phrase: "a profound impairment in the H2O2-activated, p53-dependent pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0684336:Impairment [Pathologic Function]

Phrase: "which"

Phrase: "results in a lack of activation of p53"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0079419:P53 [Gene or Genome]
   744   C0332268:lack [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1705526:p53 [Gene or Genome]
   744   C1879547:Activation [Activity]
   744   C2825142:Result [Finding]

Phrase: "or"

Phrase: "p53-target genes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0079419:Genes, p53 [Gene or Genome]
   896 E C1705526:p53 gene [Gene or Genome]
   884   C1332838:Target Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "p21,"

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "and"

Phrase: "bax."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]
Processing 00000000.tx.7: This study demonstrates a specific alteration of an intracellular pathway involved in sensing and repairing DNA damage in peripheral cells from Alzheimer's disease patients. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "a specific alteration of an intracellular pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]

Phrase: "involved in sensing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   756   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "repairing DNA damage in peripheral cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0012899:DNA Damage Repair [Genetic Function]
           DNA, repair
   790   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   783   C0599732:cells damage [Cell or Molecular Dysfunction]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1883709:Damage [Functional Concept]

Phrase: "from Alzheimer's disease patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.8: Key words: DNA damage, Human, Cell cycle, Reactive oxygen species, p21, GADD45, Bax  Introduction Top Summary Introduction Materials and Methods Results Discussion References  Free radicals are believed to be important intermediary risk factors involved in initiation and progression of neurodegeneration in Alzheimer's disease (AD) (for a review, see Prasad et al., 1999). 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "Human,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "Cell cycle,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Reactive oxygen species,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "p21,"

Phrase: "GADD45,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "Bax  Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "are"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "important intermediary risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035648:risk factors [Quantitative Concept]
   861   C1553898:risk factors [Idea or Concept]
   812   C0035647:Risk [Qualitative Concept]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "involved in initiation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0589507:Initiation [Mental Process]
   790   C1158830:Initiation [Genetic Function]
   790   C1314939:Involved [Functional Concept]
   790   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "progression of neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) (for a review,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Prasad et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.9: Free radicals, such as O-*, HO2*, R*, RO2* and H2O2, are highly unstable and reactive molecules that are generated during normal aerobic respiration, during bacterial or viral infection and during normal oxidative metabolism of several substances. 

Phrase: "Free radicals,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "such as O-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "*,"

Phrase: "HO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018969:HO2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "*,"

Phrase: "R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "*,"

Phrase: "RO2"

Phrase: "*"

Phrase: "and"

Phrase: "H2O2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "are"

Phrase: "highly unstable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443343:Unstable [Finding]
   861   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "and"

Phrase: "reactive molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "generated during normal aerobic respiration,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0282636:aerobic respiration [Cell Function]
           respiration
   760   C0035203:Respiration [Physiologic Function]
   760   C0205307:Normal [Qualitative Concept]
   760   C0439166:% normal [Quantitative Concept]
   760   C1160636:respiration [Biologic Function]
   760   C1510824:Aerobic [Qualitative Concept]
   760   C2347086:% Normal [Quantitative Concept]
   760   C3146294:Generated [Activity]

Phrase: "during bacterial"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0521009:Bacterial [Qualitative Concept]
   928 E C0004611:Bacteria [Bacterium]
   928 E C1510439:bacteria [Functional Concept]
   928 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "or"

Phrase: "viral infection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0042769:Viral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   861   C0521026:Viral [Functional Concept]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "and during normal oxidative metabolism of several substances."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0282636:oxidative metabolism [Cell Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]
   744   C0205307:Normal [Qualitative Concept]
   744   C0311404:Oxidative [Functional Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C0439861:Substances [Substance]
   744   C1515981:And [Idea or Concept]
   744   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.10: When the levels of such reactive oxygen species (ROS) exceed the antioxidant capacity of the cell, they became toxic and cause oxidative injury. 

Phrase: "When"

Phrase: "the levels of such reactive oxygen species (ROS)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "exceed"

Phrase: "the antioxidant capacity of the cell,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003402:Antioxidant [Pharmacologic Substance]
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "they"

Phrase: "became"

Phrase: "toxic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600688:toxic [Injury or Poisoning]
  1000   C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "oxidative injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.11: Mitochondria, membrane lipids, proteins and nuclear genes of highly metabolic cells are the primary targets for the action of ROS. 

Phrase: "Mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "membrane lipids,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025249:Membrane Lipids [Cell Component,Lipid]
   861   C0023779:Lipids [Lipid]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "nuclear genes of highly metabolic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017337:Genes [Gene or Genome]
   750   C1861886:CELL Gene [Gene or Genome]

Phrase: "are"

Phrase: "the primary targets for the action of ROS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1521840:Target [Functional Concept]
   706   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.12: The contribution of oxidative injury and ROS generation to AD is supported by a number of neurochemical and neuropathological studies in the brain of AD patients showing accumulation of iron and aluminium (Savory et al., 1999; Campbell and Bondy, 2000), high levels of peroxynitrite (Hensley et al., 1995; Hensley et al., 1998; Aksenov et al., 2001), high expression of heme oxygenase (Takahashi et al., 2000; Takeda et al., 2000) and high levels of markers of lipid peroxidase activity, such as thiobarbituric acid-reactive substance (Lovell et al., 1995; Marcus et al., 1998) and 4-hydroxynonenal (Lovell et al., 1997; Markesbery and Lovell, 1998). 

Phrase: "The contribution of oxidative injury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "ROS generation to AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "is"

Phrase: "supported by a number of neurochemical"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "neuropathological studies in the brain of AD patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "accumulation of iron"

Phrase: "and"

Phrase: "aluminium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Savory et al.,"

Phrase: "1999"

Phrase: "; Campbell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "and"

Phrase: "Bondy,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "high levels of peroxynitrite"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Hensley et al.,"

Phrase: "1995"

Phrase: "; Hensley et al.,"

Phrase: "1998"

Phrase: "; Aksenov et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "high expression of heme oxygenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Takahashi et al.,"

Phrase: "2000"

Phrase: "; Takeda et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "high levels of markers of lipid peroxidase activity,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0428460:levels lipid [Laboratory or Test Result]
   767   C0683317:activity levels [Finding]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "such as thiobarbituric acid-reactive substance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0076442:thiobarbituric acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0205332:Reactive [Qualitative Concept]
   812   C0439861:Substance [Substance]

Phrase: "(Lovell et al.,"

Phrase: "1995"

Phrase: "; Marcus et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "and"

Phrase: "4-hydroxynonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Lovell et al.,"

Phrase: "1997"

Phrase: "; Markesbery"

Phrase: "and"

Phrase: "Lovell,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.13: Moreover, neurotoxicity associated both with Ca2+- mediated activation of N-Methyl-D-Aspartate-type glutamate receptor and with -amyloid plaques deposition involve free radical generation (Ciani et al., 1996; Hensley et al., 1996; Mark et al., 1996; Weber, 1999). 

Phrase: "Moreover,"

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "both with Ca2+- mediated activation of N-Methyl-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0238767:Both [Spatial Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1706086:Both [Qualitative Concept]
   744   C1879547:Activation [Activity]

Phrase: "D-"

Phrase: "Aspartate-type glutamate receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0052536:receptor, aspartate [Amino Acid, Peptide, or Protein,Receptor]
   861   C0061465:Glutamate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   812   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and with -amyloid plaques deposition"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   806   C2936349:Plaques, Amyloid [Acquired Abnormality]
   797   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   797   C1705760:Amyloid Deposition [Finding]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0333562:Deposition [Functional Concept]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1515981:And [Idea or Concept]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]

Phrase: "involve"

Phrase: "free radical generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "(Ciani et al.,"

Phrase: "1996"

Phrase: "; Hensley et al.,"

Phrase: "1996"

Phrase: "; Mark et al.,"

Phrase: "1996"

Phrase: "; Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.14: Finally, clinical studies show that oral vitamin E intake or selegiline treatment delays the progression of the disease in patients with moderate to severe cognitive impairment (Sano et al., 1997). 

Phrase: "Finally,"

Phrase: "clinical studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0008972:Clinical Studies [Research Activity]
   861   C0205210:Clinical [Qualitative Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that oral vitamin E intake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0564438:Vitamin E intake [Finding]
   875   C0518041:Vitamin intake [Finding]
   812   C1512806:Intake [Functional Concept]

Phrase: "or"

Phrase: "selegiline treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "delays"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "the progression of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0242656:Disease Progression [Pathologic Function]
           progression
   797   C1947900:Disease progression NOS [Finding]
   760   C0449258:Progression [Functional Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with moderate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205081:Moderate [Qualitative Concept]
  1000   C1881878:Moderate [Qualitative Concept]

Phrase: "to severe cognitive impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3554639:Severe cognitive impairment [Finding]
   901   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   827   C0684336:Impairment [Pathologic Function]

Phrase: "(Sano et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.15: Signs of oxidative stress in AD are also detectable in peripheral cells. 

Phrase: "Signs of oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "in AD"

Phrase: "are"

Phrase: "also detectable in peripheral cells."
Processing 00000000.tx.16: Indeed, fibroblasts from sporadic AD patients show impaired oxidative metabolism (Gibson et al., 1996; Gasparini et al., 1998), lymphoblasts from familial AD patients carrying a mutation in the presenilin-1 gene have low levels of reduced glutathione (Cecchi et al., 1999), and lymphocytes from mice carrying multiple presenilin-1 mutations show an accumulation of ROS (Eckert et al., 2001). 

Phrase: "Indeed,"

Phrase: "fibroblasts from sporadic AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "impaired oxidative metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0282636:oxidative metabolism [Cell Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "(Gibson et al.,"

Phrase: "1996"

Phrase: "; Gasparini et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "lymphoblasts from familial AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0229613:Lymphoblasts [Cell]
   760   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a mutation in the presenilin-1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "low levels of reduced glutathione"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Cecchi et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lymphocytes from mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1522703:Mouse Lymphocyte [Cell]
   790   C0024264:Lymphocytes [Cell]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "multiple presenilin-1 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an accumulation of ROS"

Phrase: "(Eckert et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.17: All together, these data suggest that brain and peripheral cells of AD patients are abnormally exposed to ROS. 

Phrase: "All together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "peripheral cells of AD patients"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "abnormally"

Phrase: "exposed to ROS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.18: However, although this condition in the brain may be associated with a neuronal cell loss, no evidence is available, at least up to now, of a clear sign of pathology in peripheral organs. 

Phrase: "However,"

Phrase: "although"

Phrase: "this condition in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0393420:Brain condition NOS [Finding]
   760   C0012634:condition [Disease or Syndrome]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "associated with a neuronal cell loss,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0699040:cell associated [Cell Component]
   783   C1850496:Neuronal loss [Finding]
   753   C0007634:Cell [Cell]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1269647:Cell [Cell]
   753   C1517945:Loss [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748 E C0598940:neuron loss [Finding]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "no evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "up to now,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "of a clear sign"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0311392:Sign [Finding]
   861   C1547188:Sign [Idea or Concept]

Phrase: "of pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "in peripheral organs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]
Processing 00000000.tx.19: In this study, we evaluated the response of different human skin fibroblast cultures obtained from probable AD patients and non-AD subjects to an acute oxidative injury elicited by H2O2. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the response of different human skin fibroblast cultures"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0312646:skin response [Laboratory or Test Result]
   767   C1286259:Skin response [Clinical Attribute]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "obtained from probable AD patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0033204:Probable [Quantitative Concept]
   760   C0332148:Probable [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "non-AD subjects to an acute oxidative injury"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   711   C0681850:Subject [Group]
   711   C1550501:{Subject} [Idea or Concept]
   711   C1706203:Subject [Idea or Concept]
   711   C2349001:Subject [Human]
   711   C2697811:Subject [Functional Concept]

Phrase: "elicited by H2O2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0449265:Elicited by [Qualitative Concept]
           elicited
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.20: It is well recognized that one of the main effects following H2O2 exposure is damage to DNA molecules. 

Phrase: "It"

Phrase: "is"

Phrase: "well recognized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "that one of the main effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "H2O2 exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]

Phrase: "is"

Phrase: "damage to DNA molecules."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0012854:dna molecules [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           DNA
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C0567416:molecules [Substance]
   770   C1883709:Damage [Functional Concept]
Processing 00000000.tx.21: Cells respond to this event by arresting the cell cycle to allow repair of damaged DNA. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "respond to this event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0441471:Event [Event]

Phrase: "by arresting"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arresting [Temporal Concept]
  1000   C0392351:arresting [Governmental or Regulatory Activity]
   928 E C0311403:Inhibited [Qualitative Concept]
   928 E C3463820:Inhibiting [Activity]
   907 E C0018790:arrested [Disease or Syndrome]
   907 E C0521111:Retarded [Qualitative Concept]

Phrase: "the cell cycle to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007586:Cell Cycle [Cell Function]
   901   C1155839:Cell Cycle [Cell Function]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1511572:Cycle [Temporal Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "repair of damaged DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   856   C0012899:DNA Damage Repair [Genetic Function]
           DNA Repair
   770   C0043240:Repair, NOS [Organism Function]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]
Processing 00000000.tx.22: The damage and the ability to repair it address the cell fate in terms of re-entry into the cell cycle or inducing apoptosis. 

Phrase: "The damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "repair"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "it"

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the cell fate in terms of re-entry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1540661:cell fate [Cell Function]
   744   C1539479:FATE [Gene or Genome]

Phrase: "into the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "inducing apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.23: Thus, to compare the sensitivity of fibroblasts of AD or non-AD patients to H2O2 exposure, we took into consideration different parameters, including cell viability, the extension of DNA damage and the ability to arrest proliferation and to activate an apoptotic program. 

Phrase: "Thus,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the sensitivity of fibroblasts of AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "or"

Phrase: "non-AD patients to H2O2 exposure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1829939:{Non-patient} [Clinical Attribute]
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "we"

Phrase: "took into consideration different parameters,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0449381:Parameters [Finding]
   760   C0518609:consideration [Finding]
   760   C1705242:Different [Qualitative Concept]
   726 E C0549193:Parameter [Spatial Concept]
   726   C1515187:Take [Health Care Activity]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cell viability,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "the extension of DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "and"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an apoptotic program."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159821:apoptotic program [Cell Function]
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.24: We found that fibroblasts from AD patients are more resistant that those from non-AD subjects to H2O2. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that fibroblasts from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "are"

Phrase: "more resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332325:Resistant [Functional Concept]
   861   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "that"

Phrase: "those from non-AD subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1518422:Non [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "to H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.25: The protective mechanism involves an impairment of ROS-activated, p53-dependent cell death.  

Phrase: "The protective mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "involves"

Phrase: "an impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0684336:Impairment [Pathologic Function]

Phrase: "of ROS-activated, p53-dependent cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007587:Cell Death [Cell Function]
   793   C0007634:Cell [Cell]
   793   C0011065:Death [Organism Function]
   793   C1269647:Cell [Cell]
   793   C1306577:Death, NOS [Finding]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.26: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion References  Patients Fibroblasts from eight non-AD controls (five females, three males; mean age 70.79.2 years) and eight AD patients (six females, two males; mean age 74.08.2 years) were selected from the cell lines present in our cell repository originally established in 1993 (Govoni et al., 1993) and further expanded within MURST (Ministry of University and Research) research programs. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patients Fibroblasts from eight non-AD controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0016030:Fibroblasts [Cell]

Phrase: "(five females,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: "three males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "; mean age 70.79.2 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   876   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "eight AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "(six females,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0015780:Females [Finding]
   861   C0086287:Females [Population Group]
   827 E C0043210:female [Population Group]
   827 E C1705497:Female [Qualitative Concept]
   827 E C1705498:Female [Qualitative Concept]

Phrase: "two males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0024554:Males [Finding]
   861   C0086582:Males [Population Group]
   827 E C1706180:Male [Qualitative Concept]
   827 E C1706428:Male [Qualitative Concept]
   827 E C1706429:Male [Organism Attribute]

Phrase: "; mean age 74.08.2 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   876   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "selected from the cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   726   C1707391:Select [Activity]

Phrase: "present in our cell repository originally"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007634:Cell [Cell]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0872261:Repository [Manufactured Object]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "established in 1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443211:Established [Qualitative Concept]
   790   C1272684:Established [Qualitative Concept]

Phrase: "(Govoni et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "expanded within MURST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205229:expanded [Spatial Concept]

Phrase: "(Ministry of University"

Phrase: "and"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: ")"

Phrase: "research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "programs."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0376691:Programs [Intellectual Product]
  1000   C3484370:Programs [Functional Concept]
   966 E C1709697:Program [Conceptual Entity]
   966 E C2728259:Program [Pharmacologic Substance]
Processing 00000000.tx.27: The diagnosis of probable AD was made by senior neurologists according to the criteria developed by National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer's Disease and Related Disorders Association (ADRDA). 

Phrase: "The diagnosis of probable AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0332148:Probable diagnosis [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "made by senior neurologists"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237426:Neurologists [Professional or Occupational Group]
   770   C1705825:Senior [Idea or Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "according to the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "developed by National Institute of Neurological and Communicative Disorders and Stroke (NINCDS)"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   845   C2350584:National Institute of Neurological Disorders and Stroke [Health Care Related Organization]
   756   C0009460:Communicative Disorders [Mental or Behavioral Dysfunction]
   754   C0027765:Neurological Disorders [Disease or Syndrome]
   754   C0038454:Stroke, neurological [Disease or Syndrome]
           Stroke
   738   C0009452:Communicative [Social Behavior]
   738   C0012634:Disorders [Disease or Syndrome]
   738   C0021622:institute [Organization]
   738   C0205494:Neurological [Qualitative Concept]
   738   C1272753:Institute [Idea or Concept]
   738   C2707261:Neurological [Clinical Attribute]
   738   C3245503:national [Intellectual Product]

Phrase: "and"

Phrase: "the Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Related Disorders Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "(ADRDA"

Phrase: ")."
Processing 00000000.tx.28: All AD patients presented a 1 to 4 year history of progressive cognitive impairment predominantly affecting memory. 

Phrase: "All AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "a 1 to 4 year history of progressive cognitive impairment predominantly"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.29: Cognitive status was quantified using the Mini-Mental State Examination (MMSE); 

Phrase: "Cognitive status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449438:Status [Qualitative Concept]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Mini-Mental State Examination (MMSE)"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0451306:Mini-mental state examination [Diagnostic Procedure]
   923   C0850338:mental state examination [Therapeutic or Preventive Procedure]
   861   C0278060:Mental state [Finding]
   812   C0229992:mental [Mental Process]
   812   C0445542:Mini [Organism Attribute]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   729 E C0229993:Psychic [Functional Concept]
   712 E C0011980:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C0042241:DIAPHRAGM [Medical Device]
   712 E C1279038:Diaphragm [Body Part, Organ, or Organ Component]
   712 E C1705367:Diaphragm [Medical Device]
   701 E C0086045:mindfulness [Mental Process]
   701 E C3542996:Mindfulness [Mental Process]

Phrase: ";"
Processing 00000000.tx.30: the scores were as follows: AD, 3.62.4; 

Phrase: "the scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449820:Scores [Quantitative Concept]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "AD,"

Phrase: "3.62.4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0442757:3 4 [Finding]
   827   C0439086:<3 [Quantitative Concept]
   827   C2827736:3+ [Quantitative Concept]
   827   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.31: non-AD, 25.11.7. 

Phrase: "non-AD, 25.11.7."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0617965:AD 11 [Organic Chemical,Pharmacologic Substance]
   804   C1518422:Non [Functional Concept]
Processing 00000000.tx.32: Three AD patients were non-testable using the MMSE because of severe disease. 

Phrase: "Three AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "non-testable"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MMSE because of severe disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   800   C0850338:mental state examination [Therapeutic or Preventive Procedure]
Processing 00000000.tx.33: The ApoE genotypes were as follows: two controls were respectively heterozygous E3/E4 and E3/E2 and the others homozygous E3/E3; 

Phrase: "The ApoE genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "two controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "respectively heterozygous E3/E4"

Phrase: "and"

Phrase: "E3/E2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "the others homozygous E3/E3"

Phrase: ";"
Processing 00000000.tx.34: four AD patients were heterozygous E3/E4 and four homozygous E3/E3. 

Phrase: "four AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "heterozygous E3/E4"

Phrase: "and"

Phrase: "four homozygous E3/E3."
Processing 00000000.tx.35: Thus the overall distribution of E4 alleles was consistent with the allele frequency indicated by the literature (Frisoni et al., 1994). 

Phrase: "Thus"

Phrase: "the overall distribution of E4 alleles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "consistent with the allele frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "indicated by the literature"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C1444656:Indicated [Finding]

Phrase: "(Frisoni et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.36: A summary of demographic characteristics of all subjects enrolled in the study is reported in Table 1. 

Phrase: "A summary of demographic characteristics of all subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552616:summary [Intellectual Product]
   744   C1706244:Summary [Intellectual Product]

Phrase: "enrolled in the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "reported in Table 1."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0039224:Table [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.37: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.38: Demographic characteristics of all subjects enrolled in the study  Skin fibroblast cultures Fibroblast cultures were established as previously described (Govoni et al., 1993). 

Phrase: "Demographic characteristics of all subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0683970:demographic characteristics [Group Attribute]
   781   C0681884:subject characteristics [Research Activity]
   781   C1519021:Subject Characteristics [Organism Attribute]
   781   C1706465:Subject Characteristics [Idea or Concept]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "enrolled in the study  Skin fibroblast cultures Fibroblast cultures"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   764   C1272578:Skin fibroblast [Cell]
   742   C0010453:Cultures [Idea or Concept]
   742   C0016030:Fibroblast [Cell]
   742   C0444099:Skin [Body Substance]
   742   C0557651:Study [Manufactured Object]
   742   C1123023:Skin [Body System]
   742   C1278993:Skin [Body System]
   742   C2603343:Study [Research Activity]
   708 E C0220814:culture [Functional Concept]
   708 E C0430400:Culture [Laboratory Procedure]
   708 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "established as previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0443211:Established [Qualitative Concept]
   790   C1272684:Established [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Govoni et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.39: All cell lines were frozen at passage two-four in a modified growth medium containing 90% fetal calf serum (FCS) and 10% dimethylsulfoxide. 

Phrase: "All cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "frozen at passage two-four"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016701:Frozen [Natural Phenomenon or Process]
   760   C0205448:Two [Quantitative Concept]
   760   C0205450:Four [Quantitative Concept]
   760   C0439799:Passage [Spatial Concept]
   760   C0677542:Frozen [Functional Concept]

Phrase: "in a modified growth medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0010454:Growth Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0439536:Medium [Quantitative Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C1705217:Medium [Substance]
   827   C2911660:Growth [Activity]
   827   C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "90% fetal calf serum (FCS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "10% dimethylsulfoxide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.40: For the experiments, cell lines were simultaneously thawed and grown up to passages nine-twelve. 

Phrase: "For the experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "simultaneously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: "and"

Phrase: "grown up to passages nine-twelve."
Processing 00000000.tx.41: Cells were grown in Eagle's Minimum Essential Medium (GIBCO, Madison, WI), supplemented with 10% FCS, penicillin (100 U/ml) and streptomicin (100 g/ml), non-essential amino acid solution (1% v/v) and Tricine buffer (GIBCO) (20 mM, pH 7.4) at 37C in 5% CO2/95% air. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Eagle's Minimum Essential Medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0009458:Medium [Intellectual Product]
   753   C0205224:Essential [Qualitative Concept]
   753   C0325564:Eagle [Bird]
   753   C0439536:Medium [Quantitative Concept]
   753   C1524031:Minimum [Qualitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1552614:minimum [Idea or Concept]
   753   C1705217:Medium [Substance]
   753   C2826545:MINIMUM [Quantitative Concept]
   753   C3244283:medium [Intellectual Product]

Phrase: "(GIBCO,"

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "supplemented with 10% FCS,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0230445:Calf [Body Location or Region]
   753   C0521457:Fetal [Functional Concept]
   753   C1305418:Calf [Body Part, Organ, or Organ Component]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030842:Penicillin [Antibiotic,Organic Chemical]
  1000   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "(100 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "streptomicin"

Phrase: "(100 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "non-essential amino acid solution"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0308312:AMINO ACID SOLUTION [Clinical Drug]
   804   C0037633:Solution [Substance]
   804   C0525069:Solution [Biomedical or Dental Material]
   771   C0311461:Non-Essential Amino Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   717   C0002525:Essential amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   717   C2348468:Essential_Amino_Acid [Conceptual Entity]

Phrase: "(1% v/v)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0560268:%V/V [Quantitative Concept]
   901   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Tricine buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(GIBCO"

Phrase: ")"

Phrase: "(20 mM,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 37C"

Phrase: "in 5% CO2/95% air."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0001861:Air [Substance]
   812   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   729 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.42: The medium was changed every 3 days. 

Phrase: "The medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "every 3 days."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442459:3 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.43: As aging affects the apoptotic cell response to genotoxic stress (Suh et al., 2002), each set of experiments was done using cells from the same passage, carefully matching AD and control cultures. 

Phrase: "As aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the apoptotic cell response to genotoxic stress"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C1155291:response to genotoxic stress [Cell Function]
   804   C0149784:response to stress [Physiologic Function]
           response stress
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "(Suh et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "each"

Phrase: "set of experiments"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C0681814:Experiments [Research Activity]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cells from the same passage,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "carefully"

Phrase: "matching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150103:MATCHING [Research Activity]
  1000   C1708943:Matching [Qualitative Concept]

Phrase: "AD"

Phrase: "and"

Phrase: "control cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.44: Culture conditions were kept constant throughout the experiments. 

Phrase: "Culture conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "constant throughout the experiments."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547014:*Constant [Quantitative Concept]
   770   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.45: H2O2 treatment 80% confluent monolayers of cells were exposed to H2O2. 

Phrase: "H2O2 treatment 80% confluent monolayers of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "exposed to H2O2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.46: Briefly, culture cells were washed with phosphate buffer saline (PBS) and treated with 1 mM H2O2 for 15 minutes. 

Phrase: "Briefly,"

Phrase: "culture cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with phosphate buffer saline (PBS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "treated with 1 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   797   C1418486:MM-1 [Gene or Genome]
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 15 minutes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.47: After washing, cells were returned to full fresh medium for variable times according to the experiments. 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "returned to full fresh medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0332156:Return to [Qualitative Concept]
           Return
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C0443224:Fresh [Qualitative Concept]
   760   C0443225:Full [Qualitative Concept]
   760   C1705217:Medium [Substance]
   760   C2827486:Fresh [Body Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "for variable times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "according to the experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.48: For each cell line the experiments were repeated at least three times. 

Phrase: "For each cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "repeated at least three times."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.49: Cell viability Cell viability was evaluated 24 hours after the addition of the cytotoxic agent to the media by measuring lactate dehydrogenase (LDH) activity using the Cytoxicity Detection Kit (Boehringer Mannheim) and an ELISA reader (340 ATC, SLT LabInstruments, NC). 

Phrase: "Cell viability Cell viability"

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "24 hours after the addition of the cytotoxic agent"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   764   C0439584:24 hours [Temporal Concept]
   764   C0456696:/24 hours [Temporal Concept]
   764   C1442770:24 Hours [Temporal Concept]
   742   C0439227:hours [Temporal Concept]
   708 E C0564385:/hour [Quantitative Concept]

Phrase: "to the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "by measuring lactate dehydrogenase (LDH) activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1151154:lactate dehydrogenase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cytoxicity Detection Kit (Boehringer Mannheim"

Phrase: ")"

Phrase: "and"

Phrase: "an ELISA reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514743:Reader [Professional or Occupational Group]
   861   C1706461:Reader [Manufactured Object]

Phrase: "(340 ATC,"

Phrase: "SLT LabInstruments,"

Phrase: "NC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.50: Cytotoxicity was evaluated as a percentage of the maximum amount of releasable LDH enzyme activity, which is determined by lysing the cells with 1% of TritonX-100. 

Phrase: "Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "was"

Phrase: "evaluated as a percentage of the maximum amount"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0220825:Evaluated [Functional Concept]
   744   C0439165:Percentage [Quantitative Concept]
   744   C0806909:Maximum [Quantitative Concept]
   744   C1265611:Amount [Quantitative Concept]
   744   C1549488:Percentage [Idea or Concept]
   744   C1552615:maximum [Quantitative Concept]
   744   C1561533:Percentage [Idea or Concept]
   744   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "of releasable LDH enzyme activity,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   888   C1151154:lactate dehydrogenase activity [Molecular Function]
   840   C0243102:enzyme activity [Molecular Function]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "determined by lysing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0024348:lysing [Pathologic Function]

Phrase: "the cells with 1% of TritonX-100."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   774   C1441340:100 cells [Cell]
   762   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.51: Chromosomal condensation and DNA fragmentation were determined using the chromatin dye Hoechst 33258. 

Phrase: "Chromosomal condensation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C1155631:Chromosome Condensation [Cell Function]
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "DNA fragmentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the chromatin dye Hoechst 33258."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   812   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   812   C1325550:chromatin [Cell Component]
Processing 00000000.tx.52: After treatments, cells were stained with 1 M Hoechst 33258 for 5 minutes. 

Phrase: "After treatments,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0001758:After-Treatments [Health Care Activity]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with 1 M Hoechst 33258"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   767   C1441607:Hoechst stain [Laboratory Procedure]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "for 5 minutes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.53: After three rinses with PBS buffer, cells were fixed with 4% paraformaldehyde for 30 minutes at room temperature. 

Phrase: "After three rinses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1701810:Rinse [Functional Concept]
   827   C1882955:Rinse [Activity]

Phrase: "with PBS buffer,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 30 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456693:/30 minutes [Temporal Concept]
  1000   C1442458:30 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.54: Coverglasses were mounted and analysed under fluorescence microscope. 

Phrase: "Coverglasses"

Phrase: "were"

Phrase: "mounted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449878:mounted [Finding]
   966 E C0181909:Mount [Medical Device]

Phrase: "and"

Phrase: "analysed under fluorescence microscope."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0181839:Microscope [Medical Device]
   770   C1706379:Microscope [Medical Device]
Processing 00000000.tx.55: Western blot analysis Cells were harvested in 80 l of lysis buffer containing 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 5 mM EDTA, 1 mM phenyl methyl sulphonyl fluoride, 0.5 g/l leupeptin, 5 g/l aprotinin and 1 g/ml pepstatin. 

Phrase: "Western blot analysis Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756   C0949466:Western blot analysis [Laboratory Procedure]

Phrase: "were"

Phrase: "harvested in 80 l of lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0024348:Lysis [Pathologic Function]
   748   C1536403:lysis [Cell Function]
   714   C1512335:Harvest [Health Care Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 mM Tris-HCl (pH 7.6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM phenyl methyl sulphonyl fluoride,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   839   C0060562:methyl fluoride [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0075613:sulfonyl fluoride [Hazardous or Poisonous Substance,Inorganic Chemical]
   799   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   799   C2945751:phenyl [Chemical Viewed Structurally]

Phrase: "0.5 g/l leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "5 g/l aprotinin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C2348935:.5 L [Quantitative Concept]

Phrase: "and"

Phrase: "1 g/ml pepstatin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.56: Samples were sonicated and centrifuged at 15,000 g for 30 minutes at 4C. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "sonicated"

Phrase: "and"

Phrase: "centrifuged at 15,000 g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 30 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456693:/30 minutes [Temporal Concept]
  1000   C1442458:30 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.57: The resulting supernatants were isolated and protein content determined by a conventional method (BCA protein assay Kit, Pierce, Rockford, IL). 

Phrase: "The resulting supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "determined by a conventional method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025663:Method [Intellectual Product]
   760   C0439858:Conventional [Qualitative Concept]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]

Phrase: "(BCA protein assay Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.58: 30 g of protein extracts were electrophoresed on 12% SDS-PAGE and transferred to nitrocellulose paper (Schleicher and Schuell, Dassel, Germany). 

Phrase: "30 g of protein extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed on 12% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]
   726   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030351:Paper [Manufactured Object]
   827   C1547566:Paper [Idea or Concept]

Phrase: "(Schleicher"

Phrase: "and"

Phrase: "Schuell,"

Phrase: "Dassel,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.59: Filters were incubated at room temperature overnight with anti-p53 (1:500) (Ab240, Neo Markers), anti-p21 (1:200) (F5, Santa Cruz Biotechnology, Santa Cruz, CA), anti-Bax (1:200) (B9, Santa Cruz Biotechnology, Santa Cruz, CA), anti-GADD45 (1:200) (C4, Santa Cruz Biotechnology, Santa Cruz, CA) or anti-tubulin (1:1,500) (Ab3, Neo Markers) antibodies in 3% non-fat dried milk (Sigma). 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "incubated at room temperature overnight"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1547703:Room [Spatial Concept]

Phrase: "with anti-p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "(Ab240,"

Phrase: "Neo Markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "anti-p21"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "(F5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414509:F5 [Gene or Genome]

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "anti-Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0812198:BAX [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "(B9,"

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "anti-GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1333655:GADD45 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "(C4,"

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "or"

Phrase: "anti-tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(Ab3,"

Phrase: "Neo Markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: "antibodies in 3% non-fat dried milk"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: The secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) and a chemiluminescence blotting substrate kit (Boehringer, Mannheim, Germany) were used for immunodetection. 

Phrase: "The secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA)"

Phrase: "and"

Phrase: "a chemiluminescence blotting substrate kit (Boehringer,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "used for immunodetection."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.61: For immunoprecipitation experiments, 150 g of protein extracts were resuspended in 500 l RIPA buffer (140 mM NaCl, 10 mM Tris-HCl, pH 8.1% TritonX-100, 0.1% SDS, 1 mM Na-ortho-vanadate and 1 mM PMSF) and then incubated with 2 g/ml of mouse p53 antibody (Ab8, Neo Markers) at 4C overnight. 

Phrase: "For immunoprecipitation experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "150 g of protein extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in 500 l RIPA buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0034584:RIPA [Laboratory Procedure]

Phrase: "(140 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 mM Tris-HCl,"

Phrase: "pH 8.1% TritonX-100,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: "0.1% SDS,"

Phrase: "1 mM Na-ortho-vanadate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0042305:Vanadate [Inorganic Chemical]
   804   C0812371:Ortho- [Idea or Concept]

Phrase: "and"

Phrase: "1 mM PMSF"

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with 2 g/ml of mouse p53 antibody"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   764   C1300565:g/mL [Quantitative Concept]
   762   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762 E C1637390:mL/g [Quantitative Concept]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0079419:P53 [Gene or Genome]
   742   C0439267:g% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1705526:p53 [Gene or Genome]

Phrase: "(Ab8,"

Phrase: "Neo Markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ")"

Phrase: "at 4C overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]
Processing 00000000.tx.62: Immunocomplexes were collected with Staphylococcus aureus Protein A suspension and washed five times with RIPA buffer. 

Phrase: "Immunocomplexes"

Phrase: "were"

Phrase: "collected with Staphylococcus aureus Protein A suspension"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0038164:staphylococcus aureus protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
           Protein A
   778   C0038172:Staphylococcus aureus [Bacterium]
   778   C1318973:Staphylococcus aureus NOS [Disease or Syndrome]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0038170:Staphylococcus [Bacterium]
   748   C0038960:Suspension [Biomedical or Dental Material]
   748   C1382107:Suspension [Substance]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1705537:Suspension [Functional Concept]

Phrase: "and"

Phrase: "washed five times with RIPA buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.63: Immunoprecipitated p53 was recovered by resuspending the pellets in loading buffer, and protein was detected by western blotting with rabbit antibodies against p53 phospho-serine-15 (1:500) (Oncogene) or p53 phospho-serine392 (1:500) (Oncogene). 

Phrase: "Immunoprecipitated p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079419:P53 [Gene or Genome]
   861   C1705526:p53 [Gene or Genome]

Phrase: "was"

Phrase: "recovered by resuspending"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "the pellets in loading buffer,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0993610:pellets [Biomedical or Dental Material]
   726 E C0441436:Pellet [Manufactured Object]
   726 E C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with rabbit antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against p53 phospho-serine-15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0079419:P53 [Gene or Genome]
   812   C1705526:p53 [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "(Oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "p53 phospho-serine392"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "(Oncogene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.64: Peroxidase-conjugated goat anti-rabbit immunoglogulin G and a chemiluminescence blotting substrate kit (Boehringer, Mannheim, Germany) were used for immunodetection. 

Phrase: "Peroxidase-conjugated goat anti-rabbit immunoglogulin G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "a chemiluminescence blotting substrate kit (Boehringer,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "used for immunodetection."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.65: Evaluation of immunoreactivity was performed on immunoblots by densitometric analysis using a KLB 2222-020 Ultra Scan XL laser densitometer. 

Phrase: "Evaluation of immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0220825:Evaluation [Functional Concept]
   790   C1261322:Evaluation [Health Care Activity]

Phrase: "was"

Phrase: "performed on immunoblots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "by densitometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a KLB 2222-020 Ultra Scan XL laser densitometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0180321:Densitometer [Medical Device]
   793   C1706216:Densitometer [Medical Device]
Processing 00000000.tx.66: Immunocytochemistry analysis for 8-hydroxy-deoxyguanosine (8OH-dG) The cells were fixed in 75% ethanol at -20C. 

Phrase: "Immunocytochemistry analysis for 8-hydroxy-deoxyguanosine (8OH-dG)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fixed in 75% ethanol at -20C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001962:Ethanol [Organic Chemical]
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C2827483:Fixed [Body Substance]
Processing 00000000.tx.67: The cells were then treated with RNase (100 g/ml) in 10 mM Tris buffer (pH 7.5) containing 1 mM EDTA and 0.4 M NaCl at 37C for 1 hour, followed by an incubation with proteinase K (10 g/ml) at room temperature for 7 minutes. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with RNase"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) in 10 mM Tris buffer (pH 7.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C3642199:10^5/mL [Quantitative Concept]
   781   C3642219:10^7/mL [Quantitative Concept]
   762   C0128666:ML 7 [Organic Chemical]
   742   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mM EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.4 M NaCl at 37C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   753   C1959973:% NaCl [Quantitative Concept]

Phrase: "for 1 hour,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442450:1 Hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "followed by an incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with proteinase K"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0059256:Proteinase K [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1622131:proteinase [Molecular Function]
   861   C1708601:K' [Quantitative Concept]
   861   C1947941:Proteinase [Enzyme]

Phrase: "(10 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) at room temperature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "for 7 minutes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.68: After rinsing with PBS, DNA was denaturated by treatment with 4 N HCl for 7 minutes at room temperature. 

Phrase: "After"

Phrase: "rinsing with PBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882955:Rinsing [Activity]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "denaturated by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with 4 N HCl"

Phrase: "for 7 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.69: The pH was adjusted with 50 mM trizma base for 5 minutes followed by washing in PBS. 

Phrase: "The pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted with 50 mM trizma base"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002055:base [Inorganic Chemical]
   753   C0178499:Base [Chemical Viewed Functionally]
   753   C0456081:Adjusted [Functional Concept]
   753   C0733358:Trizma [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   753   C1880279:Base [Biomedical or Dental Material]

Phrase: "for 5 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "followed by washing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0441648:Washing [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "in PBS."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036082:Saline [Substance]
   734   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.70: Non-specific binding sites were blocked with 10% rabbit serum for 1 hour at 37C. 

Phrase: "Non-specific binding sites"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0005456:Binding Sites [Receptor]
   858   C0449604:Specific site [Spatial Concept]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked with 10% rabbit serum"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0028778:Blocked [Pathologic Function]
   760   C0034493:Rabbit [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C0332206:Blocked [Functional Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "for 1 hour"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442450:1 Hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.71: Cells were incubated with primary anti-8OH-dG antibody (1:30) (1F711, Pharmigen) at 4C overnight. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with primary anti-8OH-dG antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C0700307:Hydroxy [Inorganic Chemical]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30"

Phrase: ")"

Phrase: "(1F711,"

Phrase: "Pharmigen"

Phrase: ")"

Phrase: "at 4C overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]
Processing 00000000.tx.72: Anti-rabbit anti-mouse IgG coniugated to biotin and ABC reagents and avidin conjugated to horseradish peroxide were used. 

Phrase: "Anti-rabbit anti-mouse IgG coniugated to biotin"

Phrase: "and"

Phrase: "ABC reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "avidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conjugated to horseradish peroxide"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0031180:Peroxide [Inorganic Chemical]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.73: To localize peroxidase, cells were treated with diaminobenzidine for 10 minutes. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "peroxidase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with diaminobenzidine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 10 minutes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0456692:/10 minutes [Temporal Concept]
  1000   C1442446:10 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]
Processing 00000000.tx.74: After mounting with Permount, coverglasses were analysed by using a camera adapted to a Nikon microscope with a x20 objective. 

Phrase: "After mounting"

Phrase: "with Permount,"

Phrase: "coverglasses"

Phrase: "were"

Phrase: "analysed by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a camera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0179533:Camera [Medical Device]
  1000   C1654607:Camera [Eukaryote]
  1000   C1706254:CAMERA [Medical Device]

Phrase: "adapted to a Nikon microscope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   760   C2937289:adapted [Organic Chemical]

Phrase: "with a x20 objective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018017:Objective [Intellectual Product]
   861   C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.75: The image processing and quantitative analysis of 8OH-dG-positive cells were performed using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD). 

Phrase: "The image processing"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0178706:Image Processing [Machine Activity]
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C1709694:Processing [Activity]
   861   C3542466:Image [Intellectual Product]
   827 E C1184743:Process [Body Part, Organ, or Organ Component]
   827 E C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "quantitative analysis of 8OH-dG-positive cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Image-Pro Plus software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Media Cybernetics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010521:Cybernetics [Occupational Activity]

Phrase: "Silver Spring,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0037125:Silver [Element, Ion, or Isotope]
   861   C0241232:Spring [Temporal Concept]
   861   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   861   C1305285:Silver [Qualitative Concept]
   861   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   861   C1705204:Spring [Manufactured Object]
   777 E C0079853:Moon [Geographic Area]
   768 E C0003782:Argyria [Injury or Poisoning]
   768 E C3463959:Argyria [Eukaryote]

Phrase: "MD)."
Processing 00000000.tx.76: Data were expressed as a number of labeled positive cells in the examined field. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "expressed as a number of labeled positive cells"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   770   C0439178:% positive cells [Quantitative Concept]
           % Positive
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C1708632:Labeled [Qualitative Concept]
   744   C2825490:Positive [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C0181496:Label [Manufactured Object]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "in the examined field."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.77: The mean profile was obtained from at least three separate determinations in triplicate for each cell line. 

Phrase: "The mean profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "obtained from"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "at least three separate determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]

Phrase: "in triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "for each cell line."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.78: The statistical significance of differences between the values was made by one-way analysis of variance followed by a Student's t-test. 

Phrase: "The statistical significance of differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   806   C1709380:Statistical Significance [Quantitative Concept]
   760   C0038215:Statistical [Occupation or Discipline]
   760   C0750502:Significance [Idea or Concept]

Phrase: "between the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "made by one-way analysis of variance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   897   C1709320:One-way Analysis of Variance [Quantitative Concept]
   814   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0205447:One [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C2348152:Variance [Quantitative Concept]
   714   C1881534:Make [Functional Concept]

Phrase: "followed by a Student's t-test."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.79: Measurement of DNA synthesis Cells were seeded in 24-well culture plates at a density of about 5x104 cells per well. 

Phrase: "Measurement of DNA synthesis Cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "were"

Phrase: "seeded in 24-well culture plates"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0180454:culture plates [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1139930:plates [Medical Device]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   719 E C0005971:Plate [Medical Device]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of about 5x104 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "per well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.80: 1 Ci/ml [3H]thymidine was added to the cells 6 hours before or immediately after the H2O2 pulse. 

Phrase: "1 Ci/ml [3H]thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "added to the cells 6 hours"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0439227:hours [Temporal Concept]
   753   C1524062:Added [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C0564385:/hour [Quantitative Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1883712:Add [Functional Concept]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "before"

Phrase: "or"

Phrase: "immediately after the H2O2 pulse."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205548:Immediately [Temporal Concept]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C1947910:Pulse [Phenomenon or Process]
Processing 00000000.tx.81: Cells were then incubated for an additional time at 37C. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for an additional time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1524062:Additional [Functional Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.82: At the end of the incubation, cells were washed with ice-cold PBS and further incubated for 10 minutes at 4C with 10% trichloroacetic acid, followed by 1 N NaOH and 1 N HCl for 20 minutes at room temperature. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with ice-cold PBS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0456963:Ice cold [Qualitative Concept]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1548982:Washed [Idea or Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "incubated for 10 minutes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0456692:/10 minutes [Temporal Concept]
   833   C1442446:10 Minutes [Temporal Concept]
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C2347166:Minute [Quantitative Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with 10% trichloroacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "followed by 1 N NaOH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0332283:Followed by [Temporal Concept]
           followed
   726 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "1 N HCl for 20 minutes"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.83: The resulting solution was collected and analysed for radioactivity content. 

Phrase: "The resulting solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analysed for radioactivity content."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]
   770   C0423896:Content [Mental Process]
   770   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.84: Flow cytometry For analysis of cell cycle distribution, both floating and adherent cells were collected and fixed in 70% ethanol in distilled water and stored at -20C. 

Phrase: "Flow cytometry For analysis of cell cycle distribution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   842   C0200904:Flow cytometry, cell cycle analysis [Laboratory Procedure]
   770   C0016263:Flow Cytometry [Laboratory Procedure]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0814048:Cytometry [Laboratory Procedure]

Phrase: "both floating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708071:Float [Qualitative Concept]

Phrase: "and"

Phrase: "adherent cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C0334154:Adherent [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "fixed in 70% ethanol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1381542:70% Ethanol [Clinical Drug]
   770   C0001962:Ethanol [Organic Chemical]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in distilled water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -20C."
Processing 00000000.tx.85: After washing in PBS, the cells were treated with 100 l of ribonuclease for 5 minutes at room temperature, stained with 400 l of propidium iodide (50 g/ml) and analysed by flow cytometry using 488 nm excitation.  

Phrase: "After washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036082:Saline [Substance]
   734   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 100 l of ribonuclease"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C0071795:Ribonuclease L [Amino Acid, Peptide, or Protein,Enzyme]
   783   C1419413:RIBONUCLEASE L [Gene or Genome]
   753   C0035542:Ribonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 5 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "stained with 400 l of propidium iodide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0021966:Iodide [Inorganic Chemical]
   748   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(50 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "analysed by flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "488 nm excitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549255:Excitation [Activity]
Processing 00000000.tx.86: Results Top Summary Introduction Materials and Methods Results Discussion References  Cell viability Exposure of human skin fibroblasts to 1 mM H2O2 for 15 minutes resulted in cell loss that is detectable 24 hours later by measuring LDH release in the medium (Fig. 1A). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell viability Exposure of human skin fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "to 1 mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 15 minutes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "resulted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "in cell loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "detectable 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0439584:24 hours [Temporal Concept]
   901   C0456696:/24 hours [Temporal Concept]
   901   C1442770:24 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "later by measuring LDH release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0205087:Late [Temporal Concept]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.87: At an earlier time, that is, 12 hours after the H2O2 pulse, cells exhibited typical signs of apoptosis, such as pyknotic and shrinking nuclei as visualized by Hoechst 33258 staining, whereas the cell nuclei of untreated cells show a normal morphology (Fig. 1B). 

Phrase: "At an earlier time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: ","

Phrase: "12 hours after the H2O2 pulse,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0456695:/12 hours [Temporal Concept]
   790   C1292430:12 hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "typical signs of apoptosis,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0220912:signs [Functional Concept]
   770   C0220913:signs [Manufactured Object]
   770   C0311392:SIGNS [Finding]
   737 E C1547188:Sign [Idea or Concept]

Phrase: "such as pyknotic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0333904:Pyknosis [Cell Function]

Phrase: "and"

Phrase: "shrinking nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: "as"

Phrase: "visualized by Hoechst 33258 staining,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "whereas"

Phrase: "the cell nuclei of untreated cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   809   C0007610:Nucleus of cell [Cell Component]
           Cell Nuclei
           Nucleus
   790   C0007634:THE CELL [Cell]
           Cell
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a normal morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: View larger version (42K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.89: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.90: Biochemical (A) and morphological (B) evidence for H2O2-induced loss of human skin fibroblasts. 

Phrase: "Biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(B) evidence for H2O2-induced loss of human skin fibroblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.91: Cell viability was determined by measuring LDH activity in conditioned media (A); 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by measuring LDH activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1151154:lactate dehydrogenase activity [Molecular Function]
   790   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0022924:lactate [Organic Chemical]
   753   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0444706:measuring [Qualitative Concept]
   753   C0449770:measuring [Quantitative Concept]
   753   C1561536:*Activity [Idea or Concept]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "in conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "(A"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.92: cells in apoptosis were determined morphologically by Hoechst 33258 staining (B). 

Phrase: "cells in apoptosis"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "morphologically by Hoechst 33258 staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   781   C1441607:Hoechst stain [Laboratory Procedure]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: Cells were exposed to 1 mM H2O2 for 15 minutes, washed and analysed at different times after the lesion, as indicated at the bottom of A and in inserts in B. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 1 mM H2O2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   797   C1418486:MM-1 [Gene or Genome]
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 15 minutes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "analysed at different times"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after the lesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221198:Lesion [Finding]
  1000   C1546698:Lesion [Intellectual Product]

Phrase: "as"

Phrase: "indicated at the bottom of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1444656:Indicated [Finding]
   753   C1511276:Bottom [Spatial Concept]
   753   C1552825:bottom [Idea or Concept]

Phrase: "and in inserts"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0813036:Inserts [Medical Device]
   790   C1515981:And [Idea or Concept]
   756 E C0441587:Insert [Health Care Activity]
   756 E C1743766:Insert [Medical Device]
   756 E C1883719:Insert [Functional Concept]

Phrase: "in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.94: Bars represent means.e.m. of at least three different experiments and are from three separate cell preparations. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means.e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "of"

Phrase: "at least three different experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "and"

Phrase: "are from three separate cell preparations."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   773   C0920433:cell preparation [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0205449:Three [Quantitative Concept]
   753   C0443299:Separate [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1551058:Are [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.95: Arrows in B indicate cells in apoptosis. 

Phrase: "Arrows in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "cells in apoptosis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.96: *P<0.01 versus 0 time.  

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "0 time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.97: The experimental paradigm described above was applied to fibroblasts from probable AD patients. 

Phrase: "The experimental paradigm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681797:paradigm [Research Activity]

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "was"

Phrase: "applied to fibroblasts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016030:Fibroblasts [Cell]
   790   C0185125:Applied [Health Care Activity]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "from probable AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.98: In particular, cell cultures from eight AD patients and eight non-AD subjects at similar number of passages (nine to twelve) were challenged with 15 minutes pulse of 1 mM H2O2, cultured for an additional 24 hours and than evaluated for cell viability. 

Phrase: "In particular, cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0007585:Cell Cultures [Laboratory Procedure]
   827   C0007634:Cell [Cell]
   827   C0010453:Cultures [Idea or Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "from eight AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "eight non-AD subjects at similar number of passages"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   708   C0681850:Subject [Group]
   708   C1550501:{Subject} [Idea or Concept]
   708   C1706203:Subject [Idea or Concept]
   708   C2349001:Subject [Human]
   708   C2697811:Subject [Functional Concept]

Phrase: "(nine to twelve"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205455:Nine [Quantitative Concept]
   827   C0205458:Twelve [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "challenged with 15 minutes pulse of 1 mM H2O2,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1442447:15 Minutes [Temporal Concept]
   762   C1418486:MM-1 [Gene or Genome]
   742   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0232117:PULSE [Clinical Attribute]
   742   C0391850:Pulse [Physiologic Function]
   742   C0439232:minute [Temporal Concept]
   742   C0700321:minute [Quantitative Concept]
   742   C0702093:/minute [Temporal Concept]
   742   C1282918:Minute [Quantitative Concept]
   742   C1947910:Pulse [Phenomenon or Process]
   742   C2347166:Minute [Quantitative Concept]
   708   C0798503:Challenge [Clinical Attribute]
   708   C0805586:Challenge [Health Care Activity]
   708   C3274764:Challenge [Conceptual Entity]

Phrase: "cultured for an additional 24 hours"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0439584:24 hours [Temporal Concept]
   790   C0456696:/24 hours [Temporal Concept]
   790   C1442770:24 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   753   C1524062:Additional [Functional Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719 E C0564385:/hour [Quantitative Concept]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "and than"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "evaluated for cell viability."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0007620:Cell Viability [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0220825:Evaluated [Functional Concept]
   770   C0443348:viability [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.99: As depicted in Fig. 

Phrase: "As"

Phrase: "depicted in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.100: 2, cell death, expressed as percentage of H2O2-induced LDH release over basal, was significant lower in fibroblasts from AD (26.43.8) in comparison with those from non-AD patients (41.74.6). 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "expressed as percentage of H2O2-induced LDH release"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0022924:lactate [Organic Chemical]
   742   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030685:Release [Health Care Activity]
   742   C0205263:Induced [Functional Concept]
   742   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   742   C0391871:Release [Functional Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "over basal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "was"

Phrase: "significant lower in fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "from AD (26.43.8"

Phrase: ")"

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with those from non-AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C1829939:{Non-patient} [Clinical Attribute]
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "(41.74.6"

Phrase: ")."
Processing 00000000.tx.101: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.103: H2O2-induced cell loss of human skin fibroblasts from non-AD and AD patients. 

Phrase: "H2O2-induced cell loss of human skin fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0476193:[Q] Skin loss [Functional Concept]
   744   C1517945:Loss [Quantitative Concept]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.104: Cell viability was determined by measuring LDH activity in the conditioned media 24 hours after H2O2 exposure. 

Phrase: "Cell viability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007620:Cell Viability [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0443348:viability [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by measuring LDH activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1151154:lactate dehydrogenase activity [Molecular Function]
   790   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0022924:lactate [Organic Chemical]
   753   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0205177:Activity [Functional Concept]
   753   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0444706:measuring [Qualitative Concept]
   753   C0449770:measuring [Quantitative Concept]
   753   C1561536:*Activity [Idea or Concept]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "in the conditioned media 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0439584:24 hours [Temporal Concept]
   861   C0456696:/24 hours [Temporal Concept]
   861   C1442770:24 Hours [Temporal Concept]
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "after H2O2 exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.105: Each point represents an individual sample. 

Phrase: "Each point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an individual sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.106: Values are expressed as a percentage increase over basal values. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as a percentage increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439165:Percentage [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "over basal values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.107: The insert shows the meanss.e.m. from at least three different experiments for each sample using at least three separate cell preparations. 

Phrase: "The insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the meanss.e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "from"

Phrase: "at least three different experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "for each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "using at least three separate cell preparations."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C0920433:cell preparation [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0205449:Three [Quantitative Concept]
   748   C0443299:Separate [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1524063:Using [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0042153:use [Functional Concept]
   714   C0455052:Preparation [Health Care Activity]
   714 E C0457083:Use [Functional Concept]
   714   C1521827:Preparation [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.108: *P<0.01 versus non-AD.  

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "non-AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.109: Oxidative DNA damage One of the major events induced by H2O2 is the generation of ROS and induction of DNA damage (Gille et al., 1992). 

Phrase: "Oxidative DNA damage One of the major events"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "induced by H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "is"

Phrase: "the generation of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "induction of DNA damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(Gille et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.110: We then asked whether the low sensitivity of AD-fibroblasts to the oxidative injury was caused by a diminished capability of ROS to generate oxidative DNA damage. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "asked"

Phrase: "whether"

Phrase: "the low sensitivity of AD-fibroblasts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to the oxidative injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was"

Phrase: "caused by a diminished capability of ROS to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   739   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0205216:Diminished [Quantitative Concept]
   739   C0205332:Reactive [Qualitative Concept]
   739   C1705920:Species [Conceptual Entity]
   739   C2698977:Capability [Qualitative Concept]
   706   C0015127:cause [Functional Concept]
   706   C1524003:Cause [Conceptual Entity]

Phrase: "generate"

Phrase: "oxidative DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1883709:Damage [Functional Concept]
Processing 00000000.tx.111: DNA base oxidation was analysed in both cell groups by using a specific antibody against 8OH-dG (Shigenaga et al., 1991). 

Phrase: "DNA base oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "analysed in both cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "groups by"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0441833:Group [Idea or Concept]
   833   C0687744:group [Population Group]
   833   C1257890:Group [Population Group]
   833   C1552516:Group [Health Care Related Organization]
   833   C1552839:groups [Idea or Concept]
   833   C1705428:Group [Conceptual Entity]
   833   C1705429:Group [Population Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific antibody against 8OH-dG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Shigenaga et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.112: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 3A shows a representative immunocytochemistry analysis carried out with 8OH-dG antibody on AD and non-AD fibroblasts after treatment with H2O2. 

Phrase: "3A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative immunocytochemistry analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with 8OH-dG antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0439787:Out [Spatial Concept]
   753   C0700307:Hydroxy [Inorganic Chemical]
   753   C0849355:Out [Qualitative Concept]

Phrase: "on AD"

Phrase: "and"

Phrase: "non-AD fibroblasts after treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "with H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.114: Only scattered 8OH-dG-positive nuclei were observed in untreated non-AD fibroblasts. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "scattered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439742:Scattered [Spatial Concept]

Phrase: "8OH-dG-positive nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "observed in untreated non-AD fibroblasts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0016030:Fibroblasts [Cell]
   753   C0332155:untreated [Finding]
   753   C1441672:Observed [Functional Concept]
   753   C1518422:Non [Functional Concept]
Processing 00000000.tx.115: H2O2 treatment caused a significant increase in the number of labelled cells within 2 hours. 

Phrase: "H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant increase in the number of labelled cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "within 2 hours."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.116: H2O2-induced base DNA damage was evident also in AD fibroblasts. 

Phrase: "H2O2-induced base DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1883709:Damage [Functional Concept]

Phrase: "was"

Phrase: "evident also in AD fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.117: Quantitative analysis of DNA damage caused by H2O2 exposure was evaluated in six AD and six non-AD cell lines, counting the 8OH-dG-positive cells in at least six different fields of each sample. 

Phrase: "Quantitative analysis of DNA damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0200898:DNA analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "caused by H2O2 exposure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "evaluated in six AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205452:Six [Quantitative Concept]
   770   C0220825:Evaluated [Functional Concept]

Phrase: "and"

Phrase: "six non-AD cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "counting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "the 8OH-dG-positive cells in"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0439178:% positive cells [Quantitative Concept]
   757   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "at least six different fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "of each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.118: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.119: 3B, H2O2-induced 8OH-dG generation was similar in AD and non-AD fibroblasts. 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "H2O2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "8OH-dG generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "was"

Phrase: "similar in AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "non-AD fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.120: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.121: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.122: H2O2-induced DNA base damage of human skin fibroblasts from non-AD and AD patients. 

Phrase: "H2O2-induced DNA base damage of human skin fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   762   C0849640:damage skin [Sign or Symptom]
   742   C0010957:Damage [Injury or Poisoning]
   742   C1883709:Damage [Functional Concept]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.123: DNA damage was evaluated immunocytochemically using a specific antibody against 8OH-dG. 

Phrase: "DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "immunocytochemically"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific antibody against 8OH-dG."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.124: A shows representative images of non-AD (1,3) and AD (2,4) fibroblasts in basal conditions (1,2) and 2 hours after H2O2 treatment (3,4). 

Phrase: "A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative images of non-AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "AD (2,"

Phrase: "4"

Phrase: ")"

Phrase: "fibroblasts in basal conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "2 hours after H2O2 treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292425:2 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.125: B shows quantitative analysis of 8OH-dG-positive cells in six non-AD and six AD samples. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "quantitative analysis of 8OH-dG-positive cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0392762:Quantitative [Quantitative Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in six non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "six AD samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.126: Bars represent basal (open) and experimental (gray) values and are expressed as a percentage of positive cells per field. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "(open"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175566:Open [Spatial Concept]
   928 E C0547049:Openness [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "experimental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517586:Experimental [Qualitative Concept]

Phrase: "(gray"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ")"

Phrase: "values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "expressed as a percentage of positive cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0439178:% positive cells [Quantitative Concept]
           % Positive
   748   C0007634:Cells [Cell]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C2825490:Positive [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "per field."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
  1000   C1521738:Field [Conceptual Entity]
  1000   C2346620:Field [Conceptual Entity]
  1000   C2349184:Field [Conceptual Entity]
  1000   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.127: Values are the means.e.m. of the results from at least six different fields for each sample. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the means.e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "of the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "from"

Phrase: "at least six different fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "for each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.128: *P<0.01 versus the corresponding basal values.  

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "the corresponding basal values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.129: Cell cycle and proliferation As a normal response to DNA damage, cells arrest the cell cycle. 

Phrase: "Cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "proliferation As a normal response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0334094:Proliferation [Pathologic Function]
   760   C1514485:Proliferation [Functional Concept]

Phrase: "to DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.130: The ability of AD and non-AD fibroblasts to arrest the cell cycle and thus to diminish DNA synthesis was evaluated at different time following H2O2 treatment by measuring [3H]thymidine uptake. 

Phrase: "The ability of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "non-AD fibroblasts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016030:Fibroblasts [Cell]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "thus to"

Phrase: "diminish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "evaluated at different time"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   783   C1442103:Time Difference [Temporal Concept]
   783   C1547049:*Time Difference [Quantitative Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "H2O2 treatment by measuring"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "[3H]thymidine uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.131: [3H]thymidine was added to the cultures 6 hours before or immediately after H2O2 pulse; 

Phrase: "[3H]thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "added to the cultures 6 hours"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   753   C0010453:Cultures [Idea or Concept]
   753   C0439227:hours [Temporal Concept]
   753   C1524062:Added [Functional Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C0564385:/hour [Quantitative Concept]
   719 E C1883712:Add [Functional Concept]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "before"

Phrase: "or"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "H2O2 pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: ";"
Processing 00000000.tx.132: radioactivity incorporated into the cells was measured at different times (0, 6 and 24 hours) later. 

Phrase: "radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "incorporated into the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "measured at different times"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0040223:times [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "(0,"

Phrase: "6"

Phrase: "and"

Phrase: "24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "later."
Processing 00000000.tx.133: No significant difference in the normal cell proliferation rate was observed in untreated AD and non-AD fibroblasts (Fig. 4A,B). 

Phrase: "No significant difference in the normal cell proliferation rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "observed in untreated AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332155:untreated [Finding]
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "non-AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "(Fig. 4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.134: Six hours after cytotoxic injury, non-AD cells decreased their proliferation rate, and 24 hours later they completely lost their ability to synthesize DNA (Fig. 4A). 

Phrase: "Six hours after cytotoxic injury,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "non-AD cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "their proliferation rate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "24 hours later"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0439584:24 hours [Temporal Concept]
   901   C0456696:/24 hours [Temporal Concept]
   901   C1442770:24 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "they completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "synthesize"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.135: In AD fibroblasts, the H2O2 insult induced a temporary growth arrest, as visualized by a decreased [3H]thymidine uptake 6 hours after the insult. 

Phrase: "In AD fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "the H2O2 insult"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a temporary growth arrest,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0333951:Growth arrest [Pathologic Function]
   827   C0237477:Arrest [Temporal Concept]
   827   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "as"

Phrase: "visualized by a decreased"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0234621:Visualized [Functional Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "[3H]thymidine uptake 6 hours after the insult."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439227:hours [Temporal Concept]
   711 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.136: Then, cells recover their ability to synthesize DNA within 24 hours (Fig. 4B). 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "recover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0521108:recover [Qualitative Concept]
  1000   C2004454:recover [Organism Function]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "synthesize"

Phrase: "DNA within 24 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: The different response of AD- and non-AD fibroblasts to H2O2 can be easily visualized by comparing the rate of [3H]thymidine uptake in both cell lines between 6 hours and 24 hours (Fig. 4B). 

Phrase: "The different response of AD-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "non-AD fibroblasts to H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "can"

Phrase: "be"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "visualized by comparing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   756   C1707455:Compare [Activity]

Phrase: "the rate of [3H]thymidine uptake in both cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0243144:Uptake [Physiologic Function]
   739   C0347980:% uptake [Quantitative Concept]

Phrase: "between 6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.138: View larger version (13K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 4. 

Phrase: "4."
Processing 00000000.tx.140: [3H]Thymidine incorporation in fibroblasts from non-AD and AD patients after H2O2 treatment. 

Phrase: "[3H]Thymidine incorporation in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0243126:incorporation [Functional Concept]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD patients after H2O2 treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.141: [3H]Thymidine was added to the culture media at the times indicated by the white arrows. 

Phrase: "[3H]Thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "added to the culture media"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0162867:Media [Tissue]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1254021:Media [Tissue]
   760   C1524062:Added [Functional Concept]
   760   C2242979:Culture [Laboratory Procedure]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C1883712:Add [Functional Concept]
   726 E C3244283:medium [Intellectual Product]

Phrase: "at the times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:times [Temporal Concept]
  1000   C1632851:Times [Quantitative Concept]
   966 E C3541383:Time [Temporal Concept]
   928 E C0442043:Temporal [Spatial Concept]
   928 E C2362314:Temporal [Temporal Concept]

Phrase: "indicated by the white arrows."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007457:White [Population Group]
   760   C0043157:White [Population Group]
   760   C0220938:White [Qualitative Concept]
   760   C0336721:arrows [Manufactured Object]
   760   C1444656:Indicated [Finding]
Processing 00000000.tx.142: Cells were exposed to H2O (circles) or 1 mM H2O2 (triangles) for 15 minutes at time 0 as indicated by black arrows, then washed and cultured for additional 6 hours or 24 hours. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to H2O"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "1 mM H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "for 15 minutes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at time 0"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "as"

Phrase: "indicated by black arrows,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005680:Black [Population Group]
   770   C0027567:Black [Population Group]
   770   C0085756:Black [Population Group]
   770   C0336721:arrows [Manufactured Object]
   770   C0439541:Black [Qualitative Concept]
   770   C1444656:Indicated [Finding]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "cultured for additional 6 hours"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0439227:hours [Temporal Concept]
   760   C1524062:Additional [Functional Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C0564385:/hour [Quantitative Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "24 hours."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.143: Data are from six non-AD and six AD different cell lines and are expressed as means.e.m. of at least three separate experiments for each sample.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are from six non-AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205452:Six [Quantitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "six AD different cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "expressed as means.e.m. of"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]

Phrase: "at least three separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "for each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.144: The ability of AD and non-AD fibroblasts to arrest the cell cycle was also evaluated by measuring the distribution of the cells into the different cell cycle phases using standard DNA content analysis by flow cytometry. 

Phrase: "The ability of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "non-AD fibroblasts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016030:Fibroblasts [Cell]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "the cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also"

Phrase: "evaluated by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0220825:Evaluated [Functional Concept]
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the distribution of the cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "into the different cell cycle phases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   906   C1516337:Cell Cycle Phase [Cell Function]
   858   C2963400:Cell phase [Temporal Concept]
   812   C0585064:Phases [Temporal Concept]
   812   C1067936:Phasis [Eukaryote]
   779 E C0205390:Phase [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard DNA content analysis by flow cytometry."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0200905:Flow cytometry, DNA analysis [Laboratory Procedure]
   778   C0681915:content analysis [Research Activity]
   774   C0200898:DNA analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.145: The cell cycle pattern of non-AD fibroblasts was compared with that of AD either in basal conditions and at different times following the H2O2 pulse. 

Phrase: "The cell cycle pattern of non-AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "compared with that of AD either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Compared [Activity]

Phrase: "in basal conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and at different times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0040223:times [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the H2O2 pulse."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]
Processing 00000000.tx.146: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 5 depicts representative DNA histograms generated by flow cytometric analysis of non-AD and AD fibroblast cell lines. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "depicts"

Phrase: "representative DNA histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2348974:Histogram [Manufactured Object]

Phrase: "generated by flow cytometric analysis of non-AD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0936012:Analysis [Research Activity]
   744   C1518422:Non [Functional Concept]
   744   C1524024:analysis [Functional Concept]
   744   C3146294:Generated [Activity]
   735   C0016263:Flow Cytometries [Laboratory Procedure]

Phrase: "and"

Phrase: "AD fibroblast cell lines."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   890   C0682524:fibroblast cell line [Cell]
   861   C0007600:Cell lines [Cell]
   861   C0016030:fibroblast cell [Cell]
           Fibroblast
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.148: No differences were evident in cell cycle distribution of untreated AD and non-AD fibroblasts (Table 2). 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "evident in cell cycle distribution of untreated AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "non-AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016030:Fibroblasts [Cell]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.149: Six hours following the H2O2 pulse, cells from non-AD and AD subjects were enriched in G0/G1 phase. 

Phrase: "Six hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the H2O2 pulse,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "cells from non-AD"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "AD subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "enriched in G0/G1 phase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0079395:G1 Phase [Temporal Concept]
   797   C0079394:G0 Phase [Temporal Concept]
   760   C0205390:Phase [Temporal Concept]
   760   C0359583:enriched [Food]
Processing 00000000.tx.150: Further, at the same time point, a fraction of cells of both groups were confined in sub-G0 phase, characterizing apoptosis. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "at the same time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "a fraction of cells of both groups"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   757   C0805525:Cell Fraction [Cell Component]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "confined in sub-G0 phase,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0079394:G0 Phase [Temporal Concept]
   760   C0205390:Phase [Temporal Concept]
   760   C0542339:Sub- [Spatial Concept]
   760   C1264637:SUB [Quantitative Concept]

Phrase: "characterizing"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.151: Twenty hours later, the percentage of non-AD cells in G0/G1 phase further increased showing also an enhancement of cell fraction in sub-G0 phase. 

Phrase: "Twenty hours later,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "the percentage of non-AD cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "in G0/G1 phase further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0079394:G0 Phase [Temporal Concept]
   861   C0079395:G1 Phase [Temporal Concept]
   812   C0205390:Phase [Temporal Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "also"

Phrase: "an enhancement of cell fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "in sub-G0 phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0079394:G0 Phase [Temporal Concept]
   827   C0205390:Phase [Temporal Concept]
Processing 00000000.tx.152: On the contrary, at the same time-point, AD fibroblasts shown a pattern of cell cycle distribution comparable with that found in basal conditions. 

Phrase: "On the contrary,"

Phrase: "at the same time-point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a pattern of cell cycle distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0449775:Distribution pattern [Spatial Concept]
   753   C0449774:Pattern [Spatial Concept]

Phrase: "comparable with that"

Phrase: "found in basal conditions."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0150312:Found [Quantitative Concept]
   770   C0205112:Basal [Spatial Concept]
   737   C0012634:condition [Disease or Syndrome]
   737 E C0243095:Find [Finding]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.153: Similar results were obtained in six AD and six non-AD cell lines. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained in six AD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205452:Six [Quantitative Concept]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "six non-AD cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   840   C0007600:Cell lines [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.154: As summarized in Table 1, the G0/G1 fraction of non-AD fibroblasts progressively increased from time 0 to 20 hours after H2O2 treatment (47.2%, 55.6% and 60.0% at 0, 6 hour and 20 hours, respectively), whereas the percentage of cells in G2/M significantly diminished over time (41.5%, 10.2% and 7.8% at 0, 6 hours and 20 hours, respectively). 

Phrase: "As"

Phrase: "summarized in Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "the G0/G1 fraction of non-AD fibroblasts progressively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C1554103:Fraction [Idea or Concept]

Phrase: "increased from time 0"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0040223:Time [Temporal Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "to 20 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(47.2%,"

Phrase: "55.6%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "and"

Phrase: "60.0% at 0,"

Phrase: "6 hour"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1292428:6 hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "20 hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "respectively"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "in G2/M significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "diminished over time"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0040223:Time [Temporal Concept]
   790   C0205216:Diminished [Quantitative Concept]
   790   C3541383:Time [Temporal Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "(41.5%,"

Phrase: "10.2%"

Phrase: "and"

Phrase: "7.8% at 0,"

Phrase: "6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "20 hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.155: By contrast, the G0/G1 fraction of H2O2-treated AD cells showed a slightly increase 6 hours after injury, which was followed by a decrease at 20 hours. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the G0/G1 fraction of H2O2-treated AD cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   745   C0805525:Cell Fraction [Cell Component]
   742   C1554103:Fraction [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "6 hours after injury,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292428:6 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "followed by a decrease"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "at 20 hours."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.156: Concomitantly, the fraction of G2/M cells decreased after 6 hours and returned to control levels 20 hours after the injury. 

Phrase: "Concomitantly,"

Phrase: "the fraction of G2/M cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   767   C0805525:Cell Fraction [Cell Component]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "decreased after 6 hours"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0439227:hours [Temporal Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "to control levels 20 hours after the injury."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439227:hours [Temporal Concept]
   711 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.157: View larger version (55K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(55K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.159: Representative patterns of cell cycle phase distribution by flow cytometric analysis of fibroblasts from non-AD and AD sample in resting conditions and at different times after H2O2 treatment. 

Phrase: "Representative patterns of cell cycle phase distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0449775:distribution patterns [Spatial Concept]
   748   C0449774:Patterns [Spatial Concept]

Phrase: "by flow cytometric analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "of fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD sample in resting conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C2736123:Sample condition [Qualitative Concept]
   760   C0370003:Sample [Substance]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "and at different times"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0040223:times [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   770   C1632851:Times [Quantitative Concept]
   770   C1705242:Different [Qualitative Concept]
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "after H2O2 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.160: Cells were exposed to 1 mM H2O2 for 15 minutes, washed and cultured for an additional 6 or 20 hours (as indicated by the numbers in the inserts). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to 1 mM H2O2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   797   C1418486:MM-1 [Gene or Genome]
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 15 minutes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "cultured for an additional 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1524062:Additional [Functional Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "20 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "indicated by the numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1444656:Indicated [Finding]

Phrase: "in the inserts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0813036:Inserts [Medical Device]
   966 E C0441587:Insert [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: ")."
Processing 00000000.tx.161: Time 0 indicates that cells are in the basal condition.  

Phrase: "Time 0"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "indicates"

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are in the basal condition."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0012634:condition [Disease or Syndrome]
   760   C0205112:Basal [Spatial Concept]
   760   C0348080:Condition [Qualitative Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.162: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.163: Distribution of non-AD and AD fibroblasts in the different cell cycle phases after H2O2 exposure  p53-dependent apoptotic pathway The transcription factor p53 is one of the proteins that play an important role in the cellular response to DNA damage by controlling DNA repair, cell cycle arrest and apoptosis (for a review, see Almog and Rotter, 1997). 

Phrase: "Distribution of non-AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "AD fibroblasts in the different cell cycle phases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0016030:fibroblast cell [Cell]
           Fibroblasts

Phrase: "after H2O2 exposure  p53-dependent apoptotic pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C2984374:p53 pathway [Functional Concept]
   799   C1704259:Pathway [Molecular Function]
   799   C1705987:Pathway [Conceptual Entity]
   791   C0162638:Apoptosis Pathway [Cell Function]

Phrase: "The transcription factor p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0079419:P53 [Gene or Genome]
   827   C1705526:p53 [Gene or Genome]
   734   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "one of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the cellular response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "to DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "by controlling DNA repair,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012899:DNA Repair [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0043240:Repair, NOS [Organism Function]
   827   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "cell cycle arrest"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155873:Cell Cycle Arrest [Cell Function]
  1000   C1516332:Cell Cycle Arrest [Cell Function]
   827   C0237477:Arrest [Temporal Concept]
   827   C0392351:arrest [Governmental or Regulatory Activity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Almog"

Phrase: "and"

Phrase: "Rotter,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.164: The effect of H2O2 on p53 protein levels and p53-dependent transcriptional activity in non-AD and AD fibroblast was examined by western blot analysis. 

Phrase: "The effect of H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on p53 protein levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0080055:P53 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "p53-dependent transcriptional activity in non-AD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "AD fibroblast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblast [Cell]

Phrase: "was"

Phrase: "examined by western blot analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.165: Protein extracts from cells prior to and 2 hours following 1 mM H2O2 pulse were electrophoresed and immunoblotted with antibodies against p53 and the p53 target gene products p21, bax and GADD45. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   841   C0007592:Cell Extracts [Cell Component]
   790   C0007634:Cells [Cell]
   790   C2828366:Extract [Substance]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "prior to"

Phrase: "and"

Phrase: "2 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292425:2 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "1 mM H2O2 pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0232117:PULSE [Clinical Attribute]
   812   C0391850:Pulse [Physiologic Function]
   812   C1947910:Pulse [Phenomenon or Process]
   729 E C0034107:Pulses [Health Care Activity]

Phrase: "were"

Phrase: "electrophoresed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: "and"

Phrase: "immunoblotted with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756   C0020985:Immunoblot [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "and"

Phrase: "the p53 target gene products p21,"

Phrase: "bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]
Processing 00000000.tx.166: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.167: 6A shows representative results using fibroblasts from two non-AD (lanes 1-4) and two AD subjects (lanes 5-8). 

Phrase: "6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fibroblasts from two non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "(lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "two AD subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "(lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.168: 2 hours after the H2O2 treatment, levels of p53, p21, bax and GADD45 increased in both non-AD samples. 

Phrase: "2 hours after the H2O2 treatment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1292425:2 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "levels of p53,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "p21,"

Phrase: "bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "increased in both non-AD samples."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1518422:Non [Functional Concept]
   720   C1277697:Sample obtained [Finding]
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.169: By contrast, samples from AD patients showed anomalous results. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "samples from AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "anomalous results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.170: One sample showed a H2O2-induced increase in p53 levels that was not accompanied by similar changes in p21, bax and GADD45 (Fig. 6A, lanes 5-6). 

Phrase: "One sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a H2O2-induced increase in p53 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by similar changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in p21,"

Phrase: "bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "lanes 5-6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.171: In the other AD sample, H2O2 treatment induced a decrease in p53 and p21 levels with no changes in bax and GADD45 protein content (Fig. 6A, lanes 7-8). 

Phrase: "In the"

Phrase: "other AD sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a decrease in p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "p21 levels with no changes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45 protein content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0252265:GADD45 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "lanes 7-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.172: Data obtained in fibroblasts from six non-AD and six AD patients were evaluated by densitometric analysis and normalized as a percentage of the corresponding basal expression. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained in fibroblasts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016030:Fibroblasts [Cell]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from six non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "six AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "evaluated by densitometric analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "normalized as a percentage of the corresponding basal expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205112:Basal [Spatial Concept]
   742   C0439165:Percentage [Quantitative Concept]
   742   C1549488:Percentage [Idea or Concept]
   742   C1561533:Percentage [Idea or Concept]
   742   C1882115:Normalized [Research Activity]
Processing 00000000.tx.173: The results are illustrated in Fig. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.174: 6B. 

Phrase: "6B."
Processing 00000000.tx.175: All samples from non-AD subjects showed a significant increase in p53, p21, bax and GADD45 protein levels after H2O2 treatment. 

Phrase: "All samples from non-AD subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0370003:Sample [Substance]
   719   C2347026:Sample [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significant increase in p53,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "p21,"

Phrase: "bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45 protein levels after H2O2 treatment."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0252265:GADD45 protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.176: The same treatment did not elicit significant changes in the levels of p53, p21, bax and GADD45 in fibroblasts from AD patients. 

Phrase: "The same treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "significant changes in the levels of p53,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "p21,"

Phrase: "bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "GADD45 in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1333655:GADD45 [Gene or Genome]

Phrase: "from AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.177: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 6. 

Phrase: "6."
Processing 00000000.tx.179: Expression of p53 and p53-related gene products in fibroblasts from non-AD and AD patients: western blot analysis. 

Phrase: "Expression of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "p53-related gene products in fibroblasts"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0079419:gene p53 [Gene or Genome]
   783   C1705526:p53 gene [Gene or Genome]
   756   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017337:Gene [Gene or Genome]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: ":"

Phrase: "western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.180: (A) Protein extracts from two non-AD (lanes 1-2 and 3-4) and two AD (lanes 5-6 and 7-8) fibroblast cultures in basal conditions (lanes 1, 3, 5 and 7) and 2 hours after the H2O2 pulse (lanes 2, 4, 6 and 8) were processed with specific antibodies against p53, p21, bax, GADD45 and -tubulin, as indicated in the method section. 

Phrase: "(A) Protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from two non-AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205448:Two [Quantitative Concept]
   760   C1518422:Non [Functional Concept]
   760   C2828366:Extract [Substance]

Phrase: "(lanes 1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "two AD (lanes 5-6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0283766:AD 6 [Organic Chemical,Pharmacologic Substance]
   853   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0205448:Two [Quantitative Concept]
   771   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "7-8"

Phrase: ")"

Phrase: "fibroblast cultures in basal conditions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0010453:Cultures [Idea or Concept]
   760   C0016030:Fibroblast [Cell]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "(lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "2 hours after the H2O2 pulse"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1292425:2 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "(lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "4,"

Phrase: "6"

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "were"

Phrase: "processed with specific antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   816   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205369:Specific [Qualitative Concept]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1552740:specific [Intellectual Product]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "against p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "p21,"

Phrase: "bax,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "and -"

Phrase: "tubulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2937342:tubulin [Cell Component]

Phrase: "as"

Phrase: "indicated in the method section."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0025663:Method [Intellectual Product]
   760   C0205155:Section [Spatial Concept]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1444656:Indicated [Finding]
   760   C1522472:Section [Substance]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
Processing 00000000.tx.181: (B) Data obtained in fibroblasts from six non-AD and six AD patients in basal conditions (open bars) and after H2O2 pulse (black bars) were calculated by densitometric analysis and normalized as a percentage of basal expression. 

Phrase: "(B) Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "obtained in fibroblasts"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016030:Fibroblasts [Cell]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "from six non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "six AD patients in basal conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030705:Patients [Patient or Disabled Group]
   750   C0683521:condition patient [Finding]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "and after H2O2 pulse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0232117:PULSE [Clinical Attribute]
   770   C0391850:Pulse [Physiologic Function]
   770   C1515981:And [Idea or Concept]
   770   C1947910:Pulse [Phenomenon or Process]

Phrase: "(black bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "calculated by densitometric analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0444686:Calculated [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "normalized as a percentage of basal expression."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205112:Basal [Spatial Concept]
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   748   C1882115:Normalized [Research Activity]
Processing 00000000.tx.182: Values are expressed as meanss.e.m. of at least three separate experiments for each sample. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as meanss.e.m. of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "at least three separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "for each sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.183: *P<0.01 versus the corresponding basal values.  

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "the corresponding basal values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.184: To gain further insight into the alteration of p53 pathway in AD fibroblasts, we investigated the possible involvement of upstream regulators of p53 activation by measuring p53 phosphorylation status at ser15 and ser392 in basal conditions and after H2O2 treatment. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "further insight into the alteration of p53 pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "in AD fibroblasts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the possible involvement of upstream regulators of p53 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "by measuring p53 phosphorylation status"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449438:Status [Qualitative Concept]

Phrase: "at ser15"

Phrase: "and"

Phrase: "ser392 in basal conditions"

Phrase: "and after H2O2 treatment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1515981:And [Idea or Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.185: Phosphorylation at N-terminal sites of p53, such as at ser15, releases p53 from MDM2 binding, whereas phosphorylation at C-terminus sites, such as at ser 392, induces p53 DNA binding activity (Lakin and Jackson, 1999; Kapoor et al., 2000). 

Phrase: "Phosphorylation at N-terminal sites of p53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "such as"

Phrase: "at ser15,"

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "p53 from MDM2 binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1817303:p53 binding [Molecular Function]
   770   C0079419:P53 [Gene or Genome]
   770   C1705526:p53 [Gene or Genome]

Phrase: "whereas"

Phrase: "phosphorylation at C-terminus sites,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "such as"

Phrase: "at ser 392,"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "p53 DNA binding activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C2266866:Binding Activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   708   C1817303:p53 binding [Molecular Function]

Phrase: "(Lakin"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "1999"

Phrase: "; Kapoor et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.186: We found that p53 phosphorylation at ser15 and ser392 in non-AD fibroblasts was low in resting conditions and significantly increased after the oxidative pulse (a representative sample is shown in Fig. 7, lines 1-2). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that p53 phosphorylation at ser15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "ser392 in non-AD fibroblasts"

Phrase: "was"

Phrase: "low in resting conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "significantly"

Phrase: "increased after the oxidative pulse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205217:Increased [Quantitative Concept]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0311404:Oxidative [Functional Concept]
   760   C0391850:Pulse [Physiologic Function]
   760   C0442805:Increased [Functional Concept]
   760   C1947910:Pulse [Phenomenon or Process]

Phrase: "("

Phrase: "a representative sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "is"

Phrase: "shown in Fig. 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "lines 1-2"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.187: Phosphorylation of p53 in AD fibroblasts behaved quite differently. 

Phrase: "Phosphorylation of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "behaved"

Phrase: "quite differently."
Processing 00000000.tx.188: In one AD case (lane 3-4, Fig. 7) phosphorylation at ser15 was high in basal conditions and decreased after H2O2. 

Phrase: "In one AD case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]

Phrase: "(lane 3-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "phosphorylation at ser15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "high in basal conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "decreased after H2O2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.189: In two other AD samples (lines 5-6 and 7-8), phosphorylation at ser15 was low in basal conditions and increased after H2O2. 

Phrase: "In two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other AD samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(lines 5-6"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "7-8"

Phrase: ")"

Phrase: ","

Phrase: "phosphorylation at ser15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "low in basal conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "increased after H2O2."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.190: However, phosphorylation at ser392 was high in basal conditions and decreased after H2O2. 

Phrase: "However,"

Phrase: "phosphorylation at ser392"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "was"

Phrase: "high in basal conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "decreased after H2O2."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.191: None of the AD samples behaved like their non-AD counterpart, at least in terms of pattern of p53 phosphorylation at ser15 and ser392. 

Phrase: "None of the AD samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "behaved like their non-AD counterpart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1518422:Non [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in terms of pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "of p53 phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "at ser15"

Phrase: "and"

Phrase: "ser392."
Processing 00000000.tx.192: These results further underline the heterogeneity of AD fibroblasts and suggest that the impairment of p53 pathway may involve also upstream regulators. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "underline"

Phrase: "the heterogeneity of AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the impairment of p53 pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "involve"

Phrase: "also upstream regulators."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0182953:regulators [Medical Device]
   793 E C1704734:Regulator [Medical Device]
   793 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.193: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.194: 7. 

Phrase: "7."
Processing 00000000.tx.195: Phosphorylation status of p53 in fibroblasts from non-AD and AD patients: an immunoprecipitation study. 

Phrase: "Phosphorylation status of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449438:Status [Qualitative Concept]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "from non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: ":"

Phrase: "an immunoprecipitation study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.196: Protein extracts from one non-AD (lanes 1-2) and three AD (lanes 2-4, 5-6 and 7-8) fibroblast cultures in basal conditions (lane 1, 3, 5 and 7) and 2 hours after the H2O2 pulse (lane 2, 4, 6 and 8) were immunoprecipitated with antibodies against p53 and immunoblotted with specific antibodies against phospho ser15, phospho ser392 or p53, as indicated.   

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "extracts from one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205447:One [Quantitative Concept]
   790   C2828366:Extract [Substance]

Phrase: "non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "(lanes 1-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "three AD (lanes 2-4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205449:Three [Quantitative Concept]
   771   C1708639:Lane [Spatial Concept]

Phrase: "5-6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442749:5 6 [Finding]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7-8"

Phrase: ")"

Phrase: "fibroblast cultures in basal conditions"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0010453:Cultures [Idea or Concept]
   760   C0016030:Fibroblast [Cell]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "(lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "2 hours after the H2O2 pulse"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1292425:2 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "(lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "4,"

Phrase: "6"

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "were"

Phrase: "immunoprecipitated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "against p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "and"

Phrase: "immunoblotted with specific antibodies"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   816   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   737   C0020985:Immunoblot [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against phospho ser15,"

Phrase: "phospho ser392"

Phrase: "or"

Phrase: "p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.197: Discussion Top Summary Introduction Materials and Methods Results Discussion References  In this study we describe and demonstrate an abnormal response of AD fibroblasts to an acute oxidative injury. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "describe"

Phrase: "and"

Phrase: "demonstrate"

Phrase: "an abnormal response of AD fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "to an acute oxidative injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.198: In particular, fibroblasts from AD patients were found to be less vulnerable to the oxidative injury induced by H2O2 in comparison with fibroblasts from non-AD subjects. 

Phrase: "In particular, fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less vulnerable to the oxidative injury"

Phrase: "induced by H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "from non-AD subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]
Processing 00000000.tx.199: The protective mechanism involves an impairment of ROS-activated, p53-dependent apoptosis. 

Phrase: "The protective mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "involves"

Phrase: "an impairment of ROS-activated, p53-dependent apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.200: The main result of our study is that H2O2-induced cell death was less effective in fibroblasts from AD patients. 

Phrase: "The main result of our study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:result study [Finding]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "is"

Phrase: "that H2O2-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "less effective in fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "from AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.201: We first asked whether the low sensitivity of AD-fibroblasts to the oxidative injury was due to a diminished capability of ROS to generate oxidative DNA damage. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "asked"

Phrase: "whether"

Phrase: "the low sensitivity of AD-fibroblasts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to the oxidative injury"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "was due to a diminished capability of ROS to"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   756   C0678226:Due to [Functional Concept]
           due
   738   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0043194:WAS [Disease or Syndrome]
   738   C0205216:Diminished [Quantitative Concept]
   738   C0205332:Reactive [Qualitative Concept]
   738   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1421478:WAS [Gene or Genome]
   738   C1705920:Species [Conceptual Entity]
   738   C2698977:Capability [Qualitative Concept]
   738   C3146286:Due [Idea or Concept]

Phrase: "generate"

Phrase: "oxidative DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1883709:Damage [Functional Concept]
Processing 00000000.tx.202: This was suggested by data obtained in similar fibroblast cell lines in which alteration of some components of the mitochondrial oxidative pathways was observed (Curti et al., 1997; Gasparini et al., 1999). 

Phrase: "This"

Phrase: "was"

Phrase: "suggested by data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]
   756   C1705535:Suggest [Idea or Concept]

Phrase: "obtained in similar fibroblast cell lines"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   799   C0682524:fibroblast cell line [Cell]
   790   C0007600:Cell lines [Cell]
   790   C0016030:fibroblast cell [Cell]
           Fibroblast
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1301820:Obtained [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2348205:Similar [Qualitative Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "in which alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515926:Alteration [Idea or Concept]

Phrase: "of some components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the mitochondrial oxidative pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Curti et al.,"

Phrase: "1997"

Phrase: "; Gasparini et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.203: To this end, we evaluated the extent of ROS-induced DNA damage, as measured by 8OH-dG formation. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the extent of ROS-induced DNA damage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439792:Extent [Spatial Concept]

Phrase: "as"

Phrase: "measured by 8OH-dG formation."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C1157283:deoxyguanosine formation [Molecular Function]
   753   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C0700307:Hydroxy [Inorganic Chemical]
   753   C1522492:Formation [Functional Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.204: When improperly hydroxylated by ROS attack, guanine may become an 8-hydroxyl-guanine residue, which can bind incorrectly to adenine instead of to cytosine and cause a DNA base mismatch (Shigenaga et al., 1991). 

Phrase: "When"

Phrase: "improperly"

Phrase: "hydroxylated by ROS attack,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205332:Reactive [Qualitative Concept]
   753   C0277793:Attack, NOS [Temporal Concept]
   753   C1261512:attack [Social Behavior]
   753   C1304680:Attack [Finding]
   753   C1705920:Species [Conceptual Entity]

Phrase: "guanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "become"

Phrase: "an 8-hydroxyl-guanine residue,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1709915:Residue [Conceptual Entity]
   812   C1882936:RESIDUE [Phenomenon or Process]
   741 E C1609982:Residual [Qualitative Concept]

Phrase: "which"

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "incorrectly to adenine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001407:Adenine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "instead of"

Phrase: "to cytosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a DNA base mismatch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881865:Mismatch [Qualitative Concept]

Phrase: "(Shigenaga et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.205: Post-mortem studies demonstrated that levels of 8OH-dG were elevated in mitochondrial DNA of AD brain relative to controls (Mecocci et al., 1994). 

Phrase: "Post-mortem studies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   983   C0683946:post-mortem study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0004398:postmortem [Diagnostic Procedure]
   734   C0580205:Postmortem [Temporal Concept]
   734   C0848632:post mortem [Finding]

Phrase: "demonstrated"

Phrase: "that levels of 8OH-dG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "elevated in mitochondrial DNA of AD brain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   778   C1819717:mitochondrial DNA [Cell Component]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C3163633:Elevated [Qualitative Concept]

Phrase: "relative to controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "(Mecocci et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.206: Furthermore, lymphocytes isolated by AD patients had higher levels of 8OH-dG than controls (Mecocci et al., 1998). 

Phrase: "Furthermore,"

Phrase: "lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "isolated by AD patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "had"

Phrase: "higher levels of 8OH-dG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "than controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Mecocci et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.207: Our results did not show any difference in the ability of H2O2 to generate 8OH-dG in fibroblasts from AD and non-AD patients, suggesting that ROS are similarly generated in terms of the amount and genotoxic potency in all fibroblast cell lines. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any difference in the ability of H2O2 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "generate"

Phrase: "8OH-dG in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from AD"

Phrase: "and"

Phrase: "non-AD patients,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1829939:{Non-patient} [Clinical Attribute]
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "similarly"

Phrase: "generated in terms of the amount"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1265611:Amount [Quantitative Concept]
   753   C3146294:Generated [Activity]
   719   C1515273:Term [Temporal Concept]
   719   C1705313:Term [Idea or Concept]
   719   C2826302:TERM [Intellectual Product]

Phrase: "and"

Phrase: "genotoxic potency in all fibroblast cell lines."
Processing 00000000.tx.208: We then asked whether the lower sensitivity of AD fibroblasts to H2O2 was caused by an impairment of the cellular response to a genotoxic insult. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "asked"

Phrase: "whether"

Phrase: "the lower sensitivity of AD fibroblasts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "caused by an impairment of the cellular response"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0007634:Cellular [Cell]
   744   C0178539:Cellular [Functional Concept]
   744   C0684336:Impairment [Pathologic Function]
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "to a genotoxic insult."
Processing 00000000.tx.209: As a normal response to DNA damage, cells arrest the cell cycle to allow repair of damaged DNA (Kastan et al., 1992). 

Phrase: "As a normal response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "to DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "the cell cycle to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007586:Cell Cycle [Cell Function]
   901   C1155839:Cell Cycle [Cell Function]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1511572:Cycle [Temporal Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "repair of damaged DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   856   C0012899:DNA Damage Repair [Genetic Function]
           DNA Repair
   770   C0043240:Repair, NOS [Organism Function]
   770   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "(Kastan et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.210: In the present study, cell cycle and cell cycle phase distribution of fibroblasts was measured by incorporation of [3H]thymidine and flow cytometric analysis. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "cell cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cell cycle phase distribution of fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "measured by incorporation of [3H]thymidine"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243126:incorporation [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1442460:3H [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "flow cytometric analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.211: Both techniques gave similar results: fibroblasts from AD patients showed a fast recover from the oxidative lesion. 

Phrase: "Both techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ":"

Phrase: "fibroblasts from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "recover from the oxidative lesion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0221198:Lesion [Finding]
   760   C0311404:Oxidative [Functional Concept]
   760   C0521108:recover [Qualitative Concept]
   760   C1546698:Lesion [Intellectual Product]
   760   C2004454:recover [Organism Function]
Processing 00000000.tx.212: In fact, only 20 hours after the lesion, cell cycle phase distribution of AD fibroblasts was similar to that of controls. 

Phrase: "In fact,"

Phrase: "only 20 hours after the lesion,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "cell cycle phase distribution of AD fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "similar to that of controls."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.213: Thus, despite the similar extent of DNA damage, fibroblasts from AD patients show an accelerated re-entry into the cell cycle and a diminished induction of apoptosis. 

Phrase: "Thus,"

Phrase: "despite the similar extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "of DNA damage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "fibroblasts from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an accelerated re-entry into the cell cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705654:Entry [Intellectual Product]
   744   C2986904:RE [Idea or Concept]

Phrase: "and"

Phrase: "a diminished induction of apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.214: Among the proteins that play an important role in the cellular response to DNA damage is the tumour suppressor p53 (Ko and Prives, 1996; Almong and Rotter, 1997; Grilli and Memo, 1999). 

Phrase: "Among the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the cellular response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "to DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "the tumour suppressor p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0079419:tumor suppressor p53 [Gene or Genome]
           P53
  1000   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705526:p53 [Gene or Genome]
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "(Ko"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "and"

Phrase: "Prives,"

Phrase: "1996"

Phrase: "; Almong"

Phrase: "and"

Phrase: "Rotter,"

Phrase: "1997"

Phrase: "; Grilli"

Phrase: "and"

Phrase: "Memo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422348:MEMO [Gene or Genome]

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.215: p53 is a transcription factor that controls cell cycle arrest, DNA repair and apoptosis (for a review, see Among and Rotter, 1997). 

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "is"

Phrase: "a transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cell cycle arrest,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1155873:Cell Cycle Arrest [Cell Function]
  1000   C1516332:Cell Cycle Arrest [Cell Function]
   827   C0237477:Arrest [Temporal Concept]
   827   C0392351:arrest [Governmental or Regulatory Activity]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "DNA repair"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012899:DNA Repair [Genetic Function]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0043240:Repair, NOS [Organism Function]
   861   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see Among"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: "and"

Phrase: "Rotter,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.216: Following exposure to DNA damaging agents, p53 is phosphorylated at several sites by different kinases, including casein kinase I and II, cdc2 kinase and the DNA-activated protein kinase (Lakin and Jackson, 1999). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to DNA damaging agents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "is"

Phrase: "phosphorylated at several sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "by different kinases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "casein kinase I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0108554:Casein Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0054846:casein kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0007332:Casein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0021966:I- [Inorganic Chemical]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II,"

Phrase: "cdc2 kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the DNA-activated protein kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0212694:DNA-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C0032545:DNA Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1418707:DNA KINASE [Gene or Genome]
   861   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Lakin"

Phrase: "and"

Phrase: "Jackson,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.217: These post-transcriptional modifications activate p53, allowing this protein to accumulate into the nucleus, to bind to specific DNA sequences and to transactivate several genes including effectors of the cell cycle, such as p21 (El-Deiry et al., 1993) and GADD45 (Kastan et al., 1992), and cell death, such as bax (Miyashita et al., 1994; Oren, 1994). 

Phrase: "These post-transcriptional modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "this protein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulate into the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to specific DNA sequences"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0205369:Specific [Qualitative Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1552740:specific [Intellectual Product]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transactivate"

Phrase: "several genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "effectors of the cell cycle,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   781   C0312740:Effector Cell [Cell]

Phrase: "such as p21"

Phrase: "(El-Deiry et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: "and"

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "(Kastan et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "such as bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "(Miyashita et al.,"

Phrase: "1994"

Phrase: "; Oren,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.218: Lack of functional p53 in different cell phenotypes may shorten DNA-damage-induced cell cycle arrest and results in accelerated proliferation (Gottlieb and Oren, 1996). 

Phrase: "Lack of functional p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in different cell phenotypes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   884   C0427385:Cell phenotype [Laboratory Procedure]
   884   C1318444:Cell phenotype [Organism Attribute]
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "may"

Phrase: "shorten"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441636:shorten [Therapeutic or Preventive Procedure]
  1000   C1282927:shorten [Qualitative Concept]

Phrase: "DNA-damage-induced cell cycle arrest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1155873:Cell Cycle Arrest [Cell Function]
   861   C1516332:Cell Cycle Arrest [Cell Function]
   799   C0237477:Arrest [Temporal Concept]
   799   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "results in accelerated proliferation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0334094:Proliferation [Pathologic Function]
   770   C0521110:Accelerated [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1514485:Proliferation [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "(Gottlieb"

Phrase: "and"

Phrase: "Oren,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.219: Moreover, Li-Fraumeni syndrome fibroblasts homozygous for p53 mutation were several fold more resistant to UV cytotoxicity and exhibited much less UV-induced apoptosis than normal skin fibroblasts expressing wild-type p53 (Ford and Hanawalt, 1997; Delia et al., 1997). 

Phrase: "Moreover,"

Phrase: "Li-Fraumeni syndrome fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016030:Fibroblasts [Cell]
   756   C0079419:Li-Fraumeni syndrome [Gene or Genome]
   756   C0085390:Li-Fraumeni Syndrome [Neoplastic Process]

Phrase: "homozygous for p53 mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019904:Homozygous [Organism Attribute]

Phrase: "were"

Phrase: "several fold more resistant to UV cytotoxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "and"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "much less UV-induced apoptosis than normal skin fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C3159226:fibroblast apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]

Phrase: "expressing"

Phrase: "wild-type p53"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0079419:P53 [Gene or Genome]
   827   C1705526:p53 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Ford"

Phrase: "and"

Phrase: "Hanawalt,"

Phrase: "1997"

Phrase: "; Delia et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.220: In the present study, fibroblasts from AD patients appear to have a profound (and heterogeneous) impairment in the ROS-activated, p53-dependent pathway, which results in abnormal phosphorylation status in the resting condition and a lack of activation of p53 or p53-target genes. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "fibroblasts from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016030:Fibroblasts [Cell]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a profound"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439808:Profound [Qualitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "heterogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneous [Qualitative Concept]

Phrase: ")"

Phrase: "impairment in the ROS-activated, p53-dependent pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0684336:Impairment [Pathologic Function]

Phrase: "which"

Phrase: "results in abnormal phosphorylation status"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0459424:Abnormal result [Finding]
   797   C1550399:Result Status [Classification]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0205161:Abnormal [Qualitative Concept]
   760   C0449438:Status [Qualitative Concept]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2347472:% Abnormal [Quantitative Concept]
   760   C2699333:ABNORMAL [Intellectual Product]
   760   C2825142:Result [Finding]

Phrase: "in the resting condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "a lack of activation of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "or"

Phrase: "p53-target genes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0079419:Genes, p53 [Gene or Genome]
   896 E C1705526:p53 gene [Gene or Genome]
   884   C1332838:Target Gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.221: It is interesting that one AD sample (line 7-8 in Fig. 6 and line 3-4 in Fig. 7), with high p53 levels in resting conditions, also exhibits signs of phosphorylation at ser15 and an enrichment in G2/M phase. 

Phrase: "It"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "that one AD sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(line 7-8 in Fig. 6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205132:Line [Spatial Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "line 3-4 in Fig. 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205132:Line [Spatial Concept]
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "with high p53 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "in resting conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "also"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "signs of phosphorylation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0220912:signs [Functional Concept]
   790   C0220913:signs [Manufactured Object]
   790   C0311392:SIGNS [Finding]
   756 E C1547188:Sign [Idea or Concept]

Phrase: "at ser15"

Phrase: "and"

Phrase: "an enrichment in G2/M phase."
Processing 00000000.tx.222: These features are not generalized to all AD samples. 

Phrase: "These features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1521970:Feature [Qualitative Concept]
   966   C1706388:Feature [Conceptual Entity]
   966   C2346469:Feature [Qualitative Concept]
   966   C2348519:Feature [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generalized to all AD samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205246:Generalized [Spatial Concept]
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.223: For example, another AD cell line shows moderate p53 expression, high phosphorylation at ser392 and low G2/M enrichment. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "another AD cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "moderate p53 expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "high phosphorylation at ser392"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "low G2/M enrichment."
Processing 00000000.tx.224: These results further underline the heterogeneity of AD fibroblasts in resting conditions. 

Phrase: "These results further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "underline"

Phrase: "the heterogeneity of AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019409:Heterogeneity [Qualitative Concept]

Phrase: "in resting conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.225: p53 belongs to a growing list of transcriptional activators that are post-transcriptionally regulated by redox modulation (Hainaut and Milner, 1993; Sun and Oberley, 1996; Verhaegh et al., 1997). 

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "belongs to a growing list of transcriptional activators"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040649:Transcriptional [Genetic Function]
   744   C0745732:List [Conceptual Entity]
   744   C3272378:LIST [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "post-transcriptionally"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "regulated by redox modulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030012:Redox [Molecular Function]
   770   C0443264:Modulation [Spatial Concept]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "(Hainaut"

Phrase: "and"

Phrase: "Milner,"

Phrase: "1993"

Phrase: "; Sun"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "and"

Phrase: "Oberley,"

Phrase: "1996"

Phrase: "; Verhaegh et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.226: In fact, as a result of protein oxidation, nine of the twelve cysteine residues in p53 localized in the central DNA-binding domain can form disulfide bonds, thus altering the three-dimensional structure of the protein. 

Phrase: "In fact,"

Phrase: "as"

Phrase: "a result of protein oxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "nine of the twelve cysteine residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205455:Nine [Quantitative Concept]
   753   C0205458:Twelve [Quantitative Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "localized in the central DNA-binding domain"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C1511662:DNA Binding Domain [Amino Acid Sequence]
   778   C1148673:DNA Binding [Genetic Function]
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205099:Central [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C0392752:Localized [Spatial Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1879652:Central - [Laboratory Procedure]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "disulfide bonds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1511997:Disulfide Bond [Amino Acid Sequence]
   861   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "thus"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "the three-dimensional structure of the protein."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0450363:3-Dimensional [Spatial Concept]
   774   C0175168:protein structure [Amino Acid, Peptide, or Protein]
   774   C1510464:Protein Structure [Amino Acid, Peptide, or Protein]
   748   C0205449:Three [Quantitative Concept]
   748   C0678594:Structure [Spatial Concept]
   738 E C0582263:Structural protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.227: In this abnormal conformation, p53 loses the capability to transactivate its target genes (Parks et al., 1997). 

Phrase: "In this abnormal conformation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "loses"

Phrase: "the capability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2698977:Capability [Qualitative Concept]

Phrase: "transactivate"

Phrase: "its target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1332838:Target Gene [Gene or Genome]
   861   C0017337:Genes [Gene or Genome]

Phrase: "(Parks et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.228: However, at the present we do not know whether the lack of ROS-activated apoptosis is the result of an elevated redox status of these cells (Curti et al., 1997) or whether p53 in these fibroblasts is per se in an oxidative conformational state. 

Phrase: "However,"

Phrase: "at the present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "know"

Phrase: "whether"

Phrase: "the lack of ROS-activated apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "is"

Phrase: "the result of an elevated redox status of these cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1550399:Result Status [Classification]
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "(Curti et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: "or"

Phrase: "whether"

Phrase: "p53 in these fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079419:P53 [Gene or Genome]
   770   C1705526:p53 [Gene or Genome]

Phrase: "is"

Phrase: "per se in an oxidative conformational state."
Processing 00000000.tx.229: In this regard, when cells are exposed repeatedly to low doses of H2O2, they became resistant to subsequent higher amount of ROS that would be lethal without pre-treatment (Janssen et al., 1993), suggesting that cells can activate an adaptive genetic program against oxidative stress. 

Phrase: "In this regard,"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "repeatedly to low doses of H2O2,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C0445550:Low dose [Quantitative Concept]
   773   C1708745:Low-Dose [Research Activity]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0178602:Doses [Quantitative Concept]
   753   C0205251:low [Qualitative Concept]
   753   C0205341:Repeatedly [Functional Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]
   719 E C0869039:Dose [Quantitative Concept]
   719 E C1114758:Dose # [Clinical Attribute]
   719 E C1428722:DOS [Gene or Genome]

Phrase: "they"

Phrase: "became"

Phrase: "resistant to subsequent higher amount of ROS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332325:Resistant to [Functional Concept]
           Resistant
   742   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "that"

Phrase: "would"

Phrase: "be"

Phrase: "lethal without pre-treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3151529:Lethal [Finding]

Phrase: "(Janssen et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an adaptive genetic program against oxidative stress."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1709697:Program [Conceptual Entity]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]
Processing 00000000.tx.230: Finally, it should be noted that ROS-activated, p53-dependent pathway in fibroblasts from AD patients was completely lacking, whereas the ROS-induced cell death was decreased only by about 40%. 

Phrase: "Finally,"

Phrase: "it"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that ROS-activated, p53-dependent pathway in fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C2984374:p53 pathway [Functional Concept]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "from AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "was"

Phrase: "completely lacking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332268:Lacking [Qualitative Concept]

Phrase: "whereas"

Phrase: "the ROS-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "only by about 40%."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Only [Quantitative Concept]
   770   C0439509:/40 [Temporal Concept]
   770   C1720467:Only [Intellectual Product]
Processing 00000000.tx.231: This apparent discrepancy indicates that ROS may induce cell death by activating different pathways, including necrosis and apoptosis, and that p53-dependent apoptosis contributes only partially to the cell death induced by ROS. 

Phrase: "This apparent discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1290905:Discrepancy [Finding]

Phrase: "indicates"

Phrase: "that ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death by activating different pathways,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "and"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "that p53-dependent apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "only partially to the cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0205171:Only [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1720467:Only [Intellectual Product]
   753   C1948049:Cell [Spatial Concept]

Phrase: "induced by ROS."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0205263:Induced [Functional Concept]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.232: Preliminary data obtained in our laboratory suggest that non-AD and AD fibroblasts behaved similarly in response to cisplatin-induced apoptosis, suggesting that the p53 impairment of AD fibroblasts may affect specific death pathways (Seluanov et al., 2001). 

Phrase: "Preliminary data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "obtained in our laboratory"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C1301820:Obtained [Functional Concept]
   770   C3244292:laboratory [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that non-AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "and"

Phrase: "AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016030:Fibroblasts [Cell]

Phrase: "behaved"

Phrase: "similarly in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to cisplatin-induced apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the p53 impairment of AD fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "specific death pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "(Seluanov et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.233: The brain is particularly vulnerable to oxidative stress because of its high energy requirement and high oxygen consumption rate; 

Phrase: "The brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "particularly vulnerable to oxidative stress"

Phrase: "because of its high energy requirement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0489460:Energy requirement [Clinical Attribute]
   827   C1514873:Requirement [Functional Concept]

Phrase: "and"

Phrase: "high oxygen consumption rate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0030055:Oxygen Consumption [Clinical Attribute]
   861   C1305742:oxygen consumption [Diagnostic Procedure]
   812   C0009830:Consumption [Activity]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0871208:Rate [Activity]
   812   C1521828:Rate [Quantitative Concept]
   812   C1947907:Consumption [Physiologic Function]

Phrase: ";"
Processing 00000000.tx.234: it is also rich in peroxidizable fatty acid and has a relative deficit of antioxidant defences compared with other organs (Floyd, 1999). 

Phrase: "it"

Phrase: "is"

Phrase: "also rich in peroxidizable fatty acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0699759:Rich [Qualitative Concept]

Phrase: "and"

Phrase: "has"

Phrase: "a relative deficit of antioxidant defences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0162429:Deficit, NOS [Disease or Syndrome]
   753   C2987487:Deficit [Qualitative Concept]

Phrase: "compared with other organs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178784:organs [Body Part, Organ, or Organ Component]
   770   C1707455:Compared [Activity]

Phrase: "(Floyd,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.235: We cannot speculate at this time on whether the lack of ROS-activated, p53-dependent apoptosis is also present in the brain of AD patients. 

Phrase: "We"

Phrase: "cannot"

Phrase: "speculate at this time"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "on"

Phrase: "whether"

Phrase: "the lack of ROS-activated, p53-dependent apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0332268:lack [Qualitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "present in the brain of AD patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.236: If this is true, it is tempting to suggest that such impairment in sensing and repairing DNA damage could be responsible for generation of malfunctioning neurons, that is cells living with altered gene transcription function. 

Phrase: "If"

Phrase: "this"

Phrase: "is"

Phrase: "true,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205238:True [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "tempting"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "such impairment in sensing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "repairing DNA damage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   884   C0012899:DNA, repair [Genetic Function]
   827   C0010957:Damage [Injury or Poisoning]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1883709:Damage [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "responsible for generation of malfunctioning neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "that"

Phrase: "is"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "living with altered gene transcription function."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   790   C0040649:Gene Transcription [Genetic Function]
           Transcription
   783   C0314627:Gene function [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0031843:function [Physiologic Function]
   753   C0376558:Living [Idea or Concept]
   753   C0392747:Altered [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   719 E C1548795:Live [Qualitative Concept]
   719 E C1634625:% live [Qualitative Concept]
   719 E C2982691:Live [Activity]
Processing 00000000.tx.237: Studies in this direction are now in progress in our laboratory. 

Phrase: "Studies in this direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "now in progress in our laboratory."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1272688:progress [Functional Concept]
   753   C1280477:Progress [Functional Concept]
Processing 00000000.tx.238: In conclusion, this study shows a specific alteration of an intracellular pathway involved in sensing and repairing DNA damage in peripheral cells from AD patients. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a specific alteration of an intracellular pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]

Phrase: "involved in sensing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   756   C0036658:sense [Organ or Tissue Function]

Phrase: "and"

Phrase: "repairing DNA damage in peripheral cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0012899:DNA Damage Repair [Genetic Function]
           DNA, repair
   790   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   783   C0599732:cells damage [Cell or Molecular Dysfunction]
   753   C0010957:Damage [Injury or Poisoning]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1883709:Damage [Functional Concept]

Phrase: "from AD patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.239: Whether this is a peripheral sign of the disease requires future investigation.  

Phrase: "Whether"

Phrase: "this"

Phrase: "is"

Phrase: "a peripheral sign of the disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0311392:Sign [Finding]
   753   C1547188:Sign [Idea or Concept]

Phrase: "requires"

Phrase: "future investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.240: Acknowledgments  This work was supported in part by funds from the Italian Ministry of Education, University and Research (MIUR) and the Ministry of Health.  

Phrase: "Acknowledgments"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by funds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:Funds [Quantitative Concept]

Phrase: "from the Italian Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "(MIUR"

Phrase: ")"

Phrase: "and"

Phrase: "the Ministry of Health."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018684:Health [Idea or Concept]
   727 E C0031206:healthiness [Finding]
Processing 00000000.tx.241: References Top Summary Introduction Materials and Methods Results Discussion References  Aksenov, M. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aksenov,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.242: Y., Aksenova, M. 

Phrase: "Y.,"

Phrase: "Aksenova,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.243: V., Butterfield, D. 

Phrase: "V., Butterfield,"

Phrase: "D."
Processing 00000000.tx.244: A., Geddes, J. 

Phrase: "A.,"

Phrase: "Geddes,"

Phrase: "J."
Processing 00000000.tx.245: W. and Markesbery, W. 

Phrase: "W."

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.246: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.248: Protein oxidation in the brain in Alzheimer's disease. 

Phrase: "Protein oxidation in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1159301:protein oxidation [Molecular Function]
   760   C0030011:Oxidation [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: Neuroscience 103,373 -383.[Medline] Almong, N. and Rotter, V. 

Phrase: "Neuroscience 103,373 -383."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   812   C1552241:Neuroscience [Professional or Occupational Group]
   812   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Almong,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Rotter,"

Phrase: "V."
Processing 00000000.tx.250: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.251: Involvement of p53 in cell differentation and development. 

Phrase: "Involvement of p53 in cell differentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.252: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.253: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.254: Acta 1333,F1 -F27.[Medline] Campbell, A. and Bondy, S. 

Phrase: "Acta 1333,"

Phrase: "F1 -F27."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "A."

Phrase: "and"

Phrase: "Bondy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.255: C. 

Phrase: "C."
Processing 00000000.tx.256: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.257: Aluminum induced oxidative events and its relation to inflammation: a role for the metal in Alzheimer's disease. 

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "oxidative events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "and"

Phrase: "its relation to inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0080103:Relation [Family Group]
   770   C0869014:relation [Social Behavior]

Phrase: ":"

Phrase: "a role for the metal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.258: Cell Mol. 

Phrase: "Cell Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0027960:Mole [Neoplastic Process]
   861   C0324740:Mole [Mammal]
   861   C0439189:Mole [Quantitative Concept]
   861   C1456781:mole [Neoplastic Process]
   861   C1824986:mol [Gene or Genome]
   777 E C0026367:Molar [Body Part, Organ, or Organ Component]
   761 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.259: Biol. 

Phrase: "Biol."
Processing 00000000.tx.260: 46,721 -730. 

Phrase: "46,721 -730."
Processing 00000000.tx.261: Cecchi, C., Latorraca, S., Sorbi, S., Iantomasi, T., Favalli, F., Vincenti, M. 

Phrase: "Cecchi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Latorraca,"

Phrase: "S."

Phrase: ","

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Iantomasi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Favalli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Vincenti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.262: T. and Liguri, G. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Liguri,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.263: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.264: Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease. 

Phrase: "Gluthatione level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "altered in lymphoblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0229613:Lymphoblasts [Cell]
   790   C0392747:Altered [Functional Concept]
   790   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.265: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.266: Lett. 

Phrase: "Lett."
Processing 00000000.tx.267: 275,152 -154.[Medline] Ciani, E., Groneng, L., Voltattorni, M., Rolseth, V., Contestabile, A. and Paulsen, R. 

Phrase: "275,152 -154."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ciani,"

Phrase: "E.,"

Phrase: "Groneng,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Voltattorni,"

Phrase: "M."

Phrase: ","

Phrase: "Rolseth,"

Phrase: "V.,"

Phrase: "Contestabile,"

Phrase: "A."

Phrase: "and"

Phrase: "Paulsen,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.268: E. 

Phrase: "E."
Processing 00000000.tx.269: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.270: Inhibition of free radical production or free radical scavenging products from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons. 

Phrase: "Inhibition of free radical production"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "free radical scavenging products from the excitotoxic cell death"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1514468:Products [Entity]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "mediated by glutamate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "of cerebellar granule neurons."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   896   C0682702:Cerebellar neuron [Cell]
   827   C0007765:Cerebellar [Body Part, Organ, or Organ Component]
   827   C0010837:Granule [Cell Component]
   827   C0027882:Neurons [Cell]
   827   C0993609:Granule [Biomedical or Dental Material]
   827   C1707522:Cerebellar [Tissue]
   755 E C0205248:Granular [Qualitative Concept]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.271: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.272: 728,1 -6.[Medline] Curti, D., Rognoni, F., Gasparini, L., Cattaneo, A., Paolillo, M., Racchi, M., Zani, L., Bianchetti, A., Trabucchi, M., Bergamaschi, S. and Govoni, S. 

Phrase: "728,"

Phrase: "1 -6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Curti,"

Phrase: "D."

Phrase: ","

Phrase: "Rognoni,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gasparini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cattaneo,"

Phrase: "A.,"

Phrase: "Paolillo,"

Phrase: "M."

Phrase: ","

Phrase: "Racchi,"

Phrase: "M."

Phrase: ","

Phrase: "Zani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bianchetti,"

Phrase: "A.,"

Phrase: "Trabucchi,"

Phrase: "M."

Phrase: ","

Phrase: "Bergamaschi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Govoni,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.273: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.274: Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. 

Phrase: "Oxidative metabolism in cultured fibroblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0282636:oxidative metabolism [Cell Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "derived from sporadic Alzheimer's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205422:Sporadic [Temporal Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.275: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.276: Lett. 

Phrase: "Lett."
Processing 00000000.tx.277: 236,13 -16.[Medline] Delia, D., Goi, K., Mizutani, S., Yamada, T., Aiello, A., Fontanella, E., LaMorte, G., Iwata, S., Ishioka, C., Krajewski, S. et al. 

Phrase: "236,"

Phrase: "13 -16."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Delia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1003001:Delia [Eukaryote]

Phrase: "D."

Phrase: ","

Phrase: "Goi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mizutani,"

Phrase: "S."

Phrase: ","

Phrase: "Yamada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aiello,"

Phrase: "A.,"

Phrase: "Fontanella,"

Phrase: "E.,"

Phrase: "LaMorte,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Iwata,"

Phrase: "S."

Phrase: ","

Phrase: "Ishioka,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Krajewski,"

Phrase: "S. et al."
Processing 00000000.tx.278: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.279: Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. 

Phrase: "Dissociation between cell cycle arrest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "occur in Li-Fraumeni cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   760   C3282337:Cells [Cell]
   760   C3495095:Li+ [Element, Ion, or Isotope]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "heterozygous for p53 gene mutations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019425:Heterozygous [Organism Attribute]
Processing 00000000.tx.280: Oncogene 14,2137 -2147.[Medline] Eckert, A., Schindowski, K., Leutner, S., Luckhaus, C., Touchet, N., Czech, C. and Muller, W. 

Phrase: "Oncogene 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "2137 -2147."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Eckert,"

Phrase: "A.,"

Phrase: "Schindowski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Leutner,"

Phrase: "S."

Phrase: ","

Phrase: "Luckhaus,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Touchet,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Czech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337799:czech [Population Group]

Phrase: "C."

Phrase: "and"

Phrase: "Muller,"

Phrase: "W."
Processing 00000000.tx.281: E. 

Phrase: "E."
Processing 00000000.tx.282: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.283: Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. 

Phrase: "Alzheimer's disease-"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "like alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515926:Alteration [Idea or Concept]

Phrase: "in peripheral cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "from presenilin-1 transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.284: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.285: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.286: 8,331 -342.[Medline] El-Deiry, W. 

Phrase: "8,331 -342."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] El-Deiry,"

Phrase: "W."
Processing 00000000.tx.287: S., Tokino, T., Velculescu, V. 

Phrase: "S."

Phrase: ","

Phrase: "Tokino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Velculescu,"

Phrase: "V."
Processing 00000000.tx.288: E., Levy, D. 

Phrase: "E.,"

Phrase: "Levy,"

Phrase: "D."
Processing 00000000.tx.289: B., Parson, R., Trent, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Parson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Trent,"

Phrase: "J."
Processing 00000000.tx.290: M., Lin, D., Mercer, K. 

Phrase: "M."

Phrase: ","

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "D."

Phrase: ","

Phrase: "Mercer,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.291: E., Kinzler, K. 

Phrase: "E.,"

Phrase: "Kinzler,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.292: W. and Vogelstein, B. 

Phrase: "W."

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.293: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.294: WAF1, a potential mediator of p53 tumour suppression. 

Phrase: "WAF1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0249197:WAF1 [Gene or Genome]
  1000   C1705522:WAF1 [Gene or Genome]

Phrase: "a potential mediator of p53 tumour suppression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.295: Cell 75,817 -825.[Medline] Floyd, R. 

Phrase: "Cell 75,817 -825."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Floyd,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: A. 

Phrase: "A."
Processing 00000000.tx.297: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.298: Antioxidants, oxidative stress, and degenerative neurological disorders. 

Phrase: "Antioxidants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "degenerative neurological disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1285162:degenerative disorders [Disease or Syndrome]
   901   C0027765:Neurological Disorders [Disease or Syndrome]
   827   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.299: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.300: Soc. 

Phrase: "Soc."
Processing 00000000.tx.301: Exper. 

Phrase: "Exper."
Processing 00000000.tx.302: Bio. 

Phrase: "Bio."
Processing 00000000.tx.303: Med. 

Phrase: "Med."
Processing 00000000.tx.304: 222,236 -245. 

Phrase: "222,236 -245."
Processing 00000000.tx.305: Frisoni, G. 

Phrase: "Frisoni,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.306: B., Calabresi, L., Geroldi, C., Bianchetti, A., D'Acquarica, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Calabresi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Geroldi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bianchetti,"

Phrase: "A.,"

Phrase: "D'"

Phrase: "Acquarica,"

Phrase: "A."
Processing 00000000.tx.307: L., Govoni, S., Sirtori, C. 

Phrase: "L., Govoni,"

Phrase: "S."

Phrase: ","

Phrase: "Sirtori,"

Phrase: "C."
Processing 00000000.tx.308: R., Trabucchi, M. and Franceschini, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Trabucchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Franceschini,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.309: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.310: Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. 

Phrase: "Apolipoprotein E epsilon 4 allele in Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "vascular dementia."
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
  1000   C0011269:Dementia, Vascular [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
   745 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.311: Dementia 5, 240-242.[Medline] Ford, J. 

Phrase: "Dementia 5,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "240-242."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ford,"

Phrase: "J."
Processing 00000000.tx.312: M. and Hanawalt, P. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hanawalt,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.313: C. 

Phrase: "C."
Processing 00000000.tx.314: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.315: Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. 

Phrase: "Expression of wild-type p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "required for efficient global genomic nucleotide excision repair"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   869   C2753994:global genomic nucleotide-excision repair [Genetic Function]
           global genomic repair
   800   C0524550:Nucleotide Excision Repair [Genetic Function]
   800   C2984260:Nucleotide excision repair [Functional Concept]
   770   C0015249:Excision Repair [Genetic Function]
   744   C0015252:excision [Therapeutic or Preventive Procedure]
   744   C0017428:Genomic [Gene or Genome]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0043240:Repair, NOS [Organism Function]
   744   C0205246:Global [Spatial Concept]
   744   C0374711:Repair [Therapeutic or Preventive Procedure]
   744   C0442799:Efficient [Qualitative Concept]
   744   C0728940:Excision [Therapeutic or Preventive Procedure]
   744   C0887950:genomic [Biomedical Occupation or Discipline]
   744   C1514873:Required [Functional Concept]
   744   C2348867:Global [Qualitative Concept]
   731   C0395089:globe repair [Therapeutic or Preventive Procedure]

Phrase: "in UV-irradiated human fibroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.316: J. 

Phrase: "J."
Processing 00000000.tx.317: Biol. 

Phrase: "Biol."
Processing 00000000.tx.318: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.319: 272,28073 -28080.[Abstract/Free FullText] Gasparini, L., Racchi, M., Binetti, G., Trabucchi, M., Solerte, S. 

Phrase: "272,"

Phrase: "28073 -28080."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gasparini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Racchi,"

Phrase: "M."

Phrase: ","

Phrase: "Binetti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Trabucchi,"

Phrase: "M."

Phrase: ","

Phrase: "Solerte,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: B., Alkon, D., Etcheberrygaray, R., Gibson, G., Blass, J., Paoletti, R. and Govoni, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Alkon,"

Phrase: "D."

Phrase: ","

Phrase: "Etcheberrygaray,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gibson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Blass,"

Phrase: "J.,"

Phrase: "Paoletti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Govoni,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.321: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.322: Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. 

Phrase: "Peripheral markers in testing pathophysiological hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "diagnosing Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.323: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.324: 12,17 -34.[Abstract/Free FullText] Gibson, G., Martins, R., Blass, J. and Gandy, S. 

Phrase: "12,"

Phrase: "17 -34."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gibson,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Martins,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Blass,"

Phrase: "J."

Phrase: "and"

Phrase: "Gandy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.325: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.326: Altered oxidation and signal transduction systems in fibroblasts from Alzheimer's patients. 

Phrase: "Altered oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "signal transduction systems in fibroblasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0037083:Signal Transduction Systems [Cell Function]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "from Alzheimer's patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.327: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.328: 59,477 -489.[Medline] Gille, J. 

Phrase: "59,477 -489."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gille,"

Phrase: "J."
Processing 00000000.tx.329: J. and Joenjie, H. 

Phrase: "J."

Phrase: "and"

Phrase: "Joenjie,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.330: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.331: Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. 

Phrase: "Cell culture models for oxidative stress"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007585:Cell Culture [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "superoxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038836:Superoxide [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "versus"

Phrase: "normobaric hyperoxia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242706:Hyperoxia [Sign or Symptom]
Processing 00000000.tx.332: Mutat. 

Phrase: "Mutat."
Processing 00000000.tx.333: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.334: 275,405 -414.[Medline] Gottlieb, T. 

Phrase: "275,405 -414."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gottlieb,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.335: M. and Oren, M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Oren,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.336: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.337: p53 in growth control and neoplasia. 

Phrase: "p53 in growth control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "neoplasia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027651:Neoplasia [Neoplastic Process]
   928 E C1709160:Neoplastic [Qualitative Concept]
Processing 00000000.tx.338: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.339: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.340: Acta 1287,77 -102.[Medline] Govoni, S., Bergamaschi, S., Racchi, M., Battaini, F., Binetti, G., Bianchetti, A. and Trabucchi, M. 

Phrase: "Acta 1287,"

Phrase: "77 -102."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Govoni,"

Phrase: "S."

Phrase: ","

Phrase: "Bergamaschi,"

Phrase: "S."

Phrase: ","

Phrase: "Racchi,"

Phrase: "M."

Phrase: ","

Phrase: "Battaini,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Binetti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bianchetti,"

Phrase: "A."

Phrase: "and"

Phrase: "Trabucchi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.342: Cytosol protein kinase c downregulation in fibroblasts from Alzheimer's disease patients. 

Phrase: "Cytosol protein kinase c downregulation in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013081:Down-Regulation [Cell Function,Molecular Function]

Phrase: "from Alzheimer's disease patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.343: Neurology 43,2581 -2586.[Abstract] Grilli, M. and Memo, M. 

Phrase: "Neurology 43,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "2581 -2586."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Grilli,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Memo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422348:MEMO [Gene or Genome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.344: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.345: Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. 

Phrase: "Possible role of NF-kappaB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "p53 in the glutamate-induced pro-apoptotic neuronal pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C2984374:p53 pathway [Functional Concept]
   742   C0079419:P53 [Gene or Genome]
   742   C1705526:p53 [Gene or Genome]
Processing 00000000.tx.346: Cell Death Differ. 

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ."
Processing 00000000.tx.347: 6,22 -27.[Medline] Hainaut, P. and Milner, J. 

Phrase: "6,"

Phrase: "22 -27."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hainaut,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Milner,"

Phrase: "J."
Processing 00000000.tx.348: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.349: Redox modulation of p53 conformation and sequence specific DNA binding in vitro. 

Phrase: "Redox modulation of p53 conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "sequence specific DNA binding"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
  1000   C1624609:sequence-specific DNA binding [Genetic Function]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0205369:Specific [Qualitative Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1519249:Sequence [Functional Concept]
   812   C1552740:specific [Intellectual Product]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.350: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.351: 53,4469 -4473.[Abstract] Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. 

Phrase: "53,"

Phrase: "4469 -4473."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hall,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Subramaniam,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cole,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Harris,"

Phrase: "M."

Phrase: ","

Phrase: "Aksenov,"

Phrase: "M."

Phrase: ","

Phrase: "Aksenova,"

Phrase: "M."

Phrase: ","

Phrase: "Gabbita,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: P., Wu, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "J."
Processing 00000000.tx.353: F., Carney, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Carney,"

Phrase: "J."
Processing 00000000.tx.354: M. et al. 

Phrase: "M. et al."
Processing 00000000.tx.355: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.356: Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. 

Phrase: "Brain regional correspondence between Alzheimer's disease histopathology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "biomarkers of protein oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0005516:Biomarkers [Clinical Attribute]
Processing 00000000.tx.357: J. 

Phrase: "J."
Processing 00000000.tx.358: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.359: 65,2146 -2156.[Medline] Hensley, K., Butterfield, D. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "2146 -2156."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Butterfield,"

Phrase: "D."
Processing 00000000.tx.360: A., Hall, N., Cole, P., Subramaniam, R., Mark, R., Mattson, M. 

Phrase: "A.,"

Phrase: "Hall,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cole,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Subramaniam,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.361: P., Markesbery, W. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.362: R., Harris, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Harris,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: E., Aksenov, M. 

Phrase: "E.,"

Phrase: "Aksenov,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: Y. et al. 

Phrase: "Y. et al."
Processing 00000000.tx.365: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.366: Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease associated amyloid beta peptide. 

Phrase: "Reactive oxygen species as causal agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205332:Reactive [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]

Phrase: "in the neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "of the Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "amyloid beta peptide."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.367: Ann. 

Phrase: "Ann."
Processing 00000000.tx.368: NY. 

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.369: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.370: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.371: 786,120 -123.[Medline] Hensley, K., Maidt, M. 

Phrase: "786,120 -123."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hensley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Maidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: L., Yu, Z., Sang, H., Markesbery, W. 

Phrase: "L., Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1006780:yu [Plant]

Phrase: "Z.,"

Phrase: "Sang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1864650:SANG [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.373: R. and Floyd, R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Floyd,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: A. 

Phrase: "A."
Processing 00000000.tx.375: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.376: Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. 

Phrase: "Electrochemical analysis of protein nitrotyrosine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0259857:electrochemical analysis [Laboratory Procedure]
   797   C1514534:Protein Analysis [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "dityrosine in the Alzheimer brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0058505:dityrosine [Amino Acid, Peptide, or Protein]

Phrase: "indicates"

Phrase: "region-specific accumulation."
Processing 00000000.tx.377: J. 

Phrase: "J."
Processing 00000000.tx.378: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.379: 18,8126 -8132.[Abstract/Free FullText] Janssen, Y. 

Phrase: "18,"

Phrase: "8126 -8132."

Phrase: "[Abstract/Free FullText"

Phrase: "] Janssen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331842:Janssen [Health Care Related Organization]

Phrase: "Y."
Processing 00000000.tx.380: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.381: W., van Houten, B., Borm, P. 

Phrase: "W., van Houten,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Borm,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.382: J. 

Phrase: "J."
Processing 00000000.tx.383: A. and Mossman, B. 

Phrase: "A."

Phrase: "and"

Phrase: "Mossman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.384: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.385: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.386: Biology of disease. 

Phrase: "Biology of disease."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0005532:Biology [Biomedical Occupation or Discipline]
   718 E C0205460:Biologic [Qualitative Concept]
   718 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.387: Cell and tissue responses to oxidative damage. 

Phrase: "Cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "tissue responses to oxidative damage."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.388: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.389: Invest. 

Phrase: "Invest."
Processing 00000000.tx.390: 69,261 -274.[Medline] Kapoor, M., Hamm, R., Yan, W., Taya, Y. and Lozano, G. 

Phrase: "69,261 -274."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450388:69 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kapoor,"

Phrase: "M."

Phrase: ","

Phrase: "Hamm,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yan,"

Phrase: "W.,"

Phrase: "Taya,"

Phrase: "Y."

Phrase: "and"

Phrase: "Lozano,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.392: Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. 

Phrase: "Cooperative phosphorylation at multiple sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C1519063:Phosphorylation Site [Amino Acid Sequence]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "p53 in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079419:P53 [Gene or Genome]
   790   C1705526:p53 [Gene or Genome]

Phrase: "to UV radiation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0041625:UV Radiation [Natural Phenomenon or Process]
   861   C0034519:Radiation [Natural Phenomenon or Process]
   861   C0560559:Radiation [Quantitative Concept]
   861   C0851346:Radiation [Natural Phenomenon or Process]
   861   C1522449:Radiation [Therapeutic or Preventive Procedure]
   861   C1524020:Radiation [Therapeutic or Preventive Procedure]
   861   C1524021:Radiation [Research Activity]
Processing 00000000.tx.393: Oncogene 19,358 -364.[Medline] Kastan, M. 

Phrase: "Oncogene 19,358 -364."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0029016:Oncogene [Gene or Genome]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kastan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: B., Zhan, Q., El-Deiry, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zhan,"

Phrase: "Q.,"

Phrase: "El-Deiry,"

Phrase: "W."
Processing 00000000.tx.395: S., Carrier, F., Jacks, T., Waish, W. 

Phrase: "S."

Phrase: ","

Phrase: "Carrier,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007294:Carrier [Finding]
  1000   C0560175:Carrier [Finding]
  1000   C1706209:Carrier [Medical Device]
  1000   C3273162:Carrier [Intellectual Product]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jacks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708586:Jack [Manufactured Object]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Waish,"

Phrase: "W."
Processing 00000000.tx.396: V., Plunkett, B. 

Phrase: "V., Plunkett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.397: S., Vogelstein, B. and Forance, A. 

Phrase: "S."

Phrase: ","

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Forance,"

Phrase: "A."
Processing 00000000.tx.398: J. 

Phrase: "J."
Processing 00000000.tx.399: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.400: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. 

Phrase: "A mammalian cell cycle checkpoint pathway utilizing p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0079419:P53 [Gene or Genome]
   795   C1705526:p53 [Gene or Genome]

Phrase: "and"

Phrase: "GADD45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1333655:GADD45 [Gene or Genome]

Phrase: "is"

Phrase: "defective in ataxia-telangiectasia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]
Processing 00000000.tx.401: Cell 71,587 -597.[Medline] Ko, L. 

Phrase: "Cell 71,587 -597."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007634:Cell [Cell]
   812   C0450389:71 [Intellectual Product]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.402: J. and Prives, C. 

Phrase: "J."

Phrase: "and"

Phrase: "Prives,"

Phrase: "C."
Processing 00000000.tx.403: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.404: p53: puzzle and paradigm. 

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: ":"

Phrase: "puzzle"

Phrase: "and"

Phrase: "paradigm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681797:paradigm [Research Activity]
Processing 00000000.tx.405: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.406: 10,1054 -1072.[Medline] Lakin, N. 

Phrase: "10,"

Phrase: "1054 -1072."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lakin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.407: D. and Jackson, S. 

Phrase: "D."

Phrase: "and"

Phrase: "Jackson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.408: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.410: Regulation of p53 in response to DNA damage. 

Phrase: "Regulation of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to DNA damage."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.411: Oncogene 18,7644 -7655.[Medline] Lovell, M. 

Phrase: "Oncogene 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "7644 -7655."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.412: A., Ehmann, W. 

Phrase: "A.,"

Phrase: "Ehmann,"

Phrase: "W."
Processing 00000000.tx.413: D., Butler, S. 

Phrase: "D."

Phrase: ","

Phrase: "Butler,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402644:Butler [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.414: M. and Markesbery, W. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.415: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.417: Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. 

Phrase: "Elevated thiobarbituric acid-reactive substances"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0162781:Thiobarbituric Acid Reactive Substances [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   853   C0001128:acid substances [Chemical]
           Acid
   840   C0076442:thiobarbituric acid [Organic Chemical]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0205332:Reactive [Qualitative Concept]
   804   C0439861:Substances [Substance]

Phrase: "and"

Phrase: "antioxidant enzyme activity in the brain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0243102:enzyme activity [Molecular Function]
   783   C0443158:Brain activity [Physiologic Function]
   783   C1148564:antioxidant activity [Molecular Function]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.418: Neurology 45,1594 -1601.[Abstract] Lovell, M. 

Phrase: "Neurology 45,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1594 -1601."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: A., Ehmann, W. 

Phrase: "A.,"

Phrase: "Ehmann,"

Phrase: "W."
Processing 00000000.tx.420: D., Mattson, M. 

Phrase: "D."

Phrase: ","

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.421: P. and Markesbery, W. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.422: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.423: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.424: Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. 

Phrase: "Elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "4-hydroxynonenal in ventricular fluid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.425: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.426: Aging 18,457 -461.[Medline] Marcus, D. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "18,457 -461."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marcus,"

Phrase: "D."
Processing 00000000.tx.427: L., Thomas, C., Rodriguez, C., Simberkoff, K., Tsai, J. 

Phrase: "L., Thomas,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rodriguez,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Simberkoff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "J."
Processing 00000000.tx.428: S., Strafaci, J. 

Phrase: "S."

Phrase: ","

Phrase: "Strafaci,"

Phrase: "J."
Processing 00000000.tx.429: A. and Freedmann, M. 

Phrase: "A."

Phrase: "and"

Phrase: "Freedmann,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.431: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.432: Increase peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. 

Phrase: "Increase peroxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "and"

Phrase: "reduced antioxidant enzyme activity in Alzheimer's disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0243102:enzyme activity [Molecular Function]
   774   C0086439:Reduced Activity [Sign or Symptom]
   774   C1148564:antioxidant activity [Molecular Function]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.433: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.434: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.435: 150,40 -44.[Medline] Mark, R. 

Phrase: "150,"

Phrase: "40 -44."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.436: J., Blanc, E. 

Phrase: "J.,"

Phrase: "Blanc,"

Phrase: "E."
Processing 00000000.tx.437: M. and Mattson, M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.439: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.440: Amyloid beta peptide and oxidative injury in Alzheimer's disease. 

Phrase: "Amyloid beta peptide"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0078939:Amyloid beta-Peptide [Amino Acid, Peptide, or Protein]
  1000   C0611285:Amyloid Beta-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Amyloid
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "oxidative injury in Alzheimer's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0178237:disease injury [Disease or Syndrome]
   760   C3263722:Injury [Injury or Poisoning]
   760   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.441: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.442: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.443: 12,211 -224.[Medline] Markesbery, W. 

Phrase: "12,211 -224."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Markesbery,"

Phrase: "W."
Processing 00000000.tx.444: R. and Lovell, M. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lovell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.445: A. 

Phrase: "A."
Processing 00000000.tx.446: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.447: 4-hydroxynonenal, a product of lipidic peroxidation, is increased in the brain in Alzheimer's disease. 

Phrase: "4-hydroxynonenal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxynonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "a product of lipidic peroxidation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "is"

Phrase: "increased in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.448: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.449: Aging 19, 33-36.[Medline] Mecocci, P., MacGarvey, U. and Beal, M. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "19,"

Phrase: "33-36."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mecocci,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "MacGarvey,"

Phrase: "U."

Phrase: "and"

Phrase: "Beal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.450: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.451: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.452: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. 

Phrase: "Oxidative damage to mitochondrial DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   797   C1096176:Mitochondrial Damage [Pathologic Function]
   760   C0010957:Damage [Injury or Poisoning]
   760   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "increased in Alzheimer's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   773   C0277564:Acquired disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.453: Ann. 

Phrase: "Ann."
Processing 00000000.tx.454: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.455: 36,747 -751.[Medline] Mecocci, P., Polidori, M. 

Phrase: "36,747 -751."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mecocci,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polidori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.456: C., Ingegni, T., Cherubini, A., Chionne, F., Cecchetti, R. and Senin, U. 

Phrase: "C., Ingegni,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cherubini,"

Phrase: "A.,"

Phrase: "Chionne,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cecchetti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Senin,"

Phrase: "U."
Processing 00000000.tx.457: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.458: Oxidative damage to DNA in lymphocytes from Ad patients. 

Phrase: "Oxidative damage to DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   770   C0010957:Damage [Injury or Poisoning]
   770   C1883709:Damage [Functional Concept]

Phrase: "in lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "from Ad patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.459: Neurology 51,1014 -1017.[Abstract] Miyashita, T., Krajewshi, S., Krajewska, M., Wang, H. 

Phrase: "Neurology 51,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1014 -1017."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miyashita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Krajewshi,"

Phrase: "S."

Phrase: ","

Phrase: "Krajewska,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.460: G., Lin, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: K., Liebermann, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liebermann,"

Phrase: "D."
Processing 00000000.tx.462: A., Hoffman, B. and Reed, J. 

Phrase: "A.,"

Phrase: "Hoffman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.463: C. 

Phrase: "C."
Processing 00000000.tx.464: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.465: Tumor suppressor p53 is a regulator of bc12 and bax gene expression in vivo and in vitro. 

Phrase: "Tumor suppressor p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0079419:tumor suppressor p53 [Gene or Genome]
           P53
  1000   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705526:p53 [Gene or Genome]
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "is"

Phrase: "a regulator of bc12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0182953:REGULATOR [Medical Device]
   770   C1704734:Regulator [Medical Device]
   770   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "bax gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C0812198:BAX gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.466: Oncogene 9,1799 -1805.[Medline] Oren, M. 

Phrase: "Oncogene 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1799 -1805."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Oren,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.467: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.468: Relationship of p53 to the control of apoptotic cell death. 

Phrase: "Relationship of p53"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "to the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "of apoptotic cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.469: Semin. 

Phrase: "Semin."
Processing 00000000.tx.470: Cancer Biol. 

Phrase: "Cancer Biol."
Processing 00000000.tx.471: 5, 221-227.[Medline] Parks, D., Bolinger, R. and Mann, K. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "221-227."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562547:parks [Manufactured Object]
   966 E C3160718:PARK [Disease or Syndrome]

Phrase: "D."

Phrase: ","

Phrase: "Bolinger,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Mann,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.472: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.473: Redox state regulates binding of p53 to sequence-specific DNA, but not to non-specific or mismatched DNA. 

Phrase: "Redox state"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0030012:redox state [Molecular Function]
           Redox
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "regulates"

Phrase: "binding of p53 to sequence-specific DNA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1624609:sequence-specific DNA binding [Genetic Function]
   774   C1148673:DNA Binding [Genetic Function]
   774   C1817303:p53 binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "but"

Phrase: "not to non-specific"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0205370:Non-specific [Qualitative Concept]
   770   C0205369:Specific [Qualitative Concept]
   770   C1518422:Non [Functional Concept]
           Not
   770   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "mismatched DNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.474: Nucleic Acid Res. 

Phrase: "Nucleic Acid Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic acid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.475: 25,1289 -1295.[Abstract/Free FullText] Prasad, K. 

Phrase: "25,"

Phrase: "1289 -1295."

Phrase: "[Abstract/Free FullText"

Phrase: "] Prasad,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.476: N., Cole, W. 

Phrase: "N., Cole,"

Phrase: "W."
Processing 00000000.tx.477: C., Hovland, A. 

Phrase: "C., Hovland,"

Phrase: "A."
Processing 00000000.tx.478: R., Prasad, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Prasad,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.479: C., Nahreini, P., Kumar, B., Edwards-Prasad, J. and Andreatta, C. 

Phrase: "C., Nahreini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kumar,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Edwards-Prasad,"

Phrase: "J."

Phrase: "and"

Phrase: "Andreatta,"

Phrase: "C."
Processing 00000000.tx.480: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.481: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.482: Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale. 

Phrase: "Multiple antioxidants in the prevention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "and"

Phrase: "treatment of neurodegenerative disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: ":"

Phrase: "analysis of biologic rationale."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.483: Curr. 

Phrase: "Curr."
Processing 00000000.tx.484: Opin. 

Phrase: "Opin."
Processing 00000000.tx.485: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.486: 12,761 -770.[Medline] Sano, M., Ernesto, C., Thomas, R. 

Phrase: "12,761 -770."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sano,"

Phrase: "M."

Phrase: ","

Phrase: "Ernesto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Thomas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.487: G., Klauber, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Klauber,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: R., Schafer, K., Graudmann, M., Woodbury, P., Growdon, J., Cotman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Schafer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Graudmann,"

Phrase: "M."

Phrase: ","

Phrase: "Woodbury,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Growdon,"

Phrase: "J.,"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.489: W., Pfeiffer, E. et al. 

Phrase: "W., Pfeiffer,"

Phrase: "E. et al."
Processing 00000000.tx.490: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.491: A controlled trail of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. 

Phrase: "A controlled trail of selegiline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1336646:TRAIL [Gene or Genome]

Phrase: "alpha-tocopherol,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0969677:.ALPHA.-Tocopherol [Lipid,Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C1142098:Alpha Tocopherol [Laboratory Procedure]
   861   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
   861   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "or"

Phrase: "both as treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0238767:Both [Spatial Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C1706086:Both [Qualitative Concept]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "for Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.492: The Alzheimer's disease corporation study. 

Phrase: "The Alzheimer's disease corporation study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.493: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.494: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.495: J. 

Phrase: "J."
Processing 00000000.tx.496: Med. 

Phrase: "Med."
Processing 00000000.tx.497: 336,1216 -1222.[Abstract/Free FullText] Savory, J., Rao, J. 

Phrase: "336,"

Phrase: "1216 -1222."

Phrase: "[Abstract/Free FullText"

Phrase: "] Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.498: K., Huang, Y., Letada, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Letada,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.499: R. and Herman, M. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.500: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.501: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.502: Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. 

Phrase: "Age-related hippocampal changes in Bcl-2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "Bax ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "associated with aluminum-induced neurodegeneration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   760   C0205263:Induced [Functional Concept]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "increased susceptibility with aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.503: Neurotoxicology, 20,805 -817.[Medline] Seluanov, A., Gorbunova, V., Falcovitz, A., Sigal, A., Milyavsky, M., Zurer, I., Shohat, G., Goldfinger, N. and Rotter, V. 

Phrase: "Neurotoxicology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597059:neurotoxicology [Organism Function]

Phrase: "20,805 -817."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seluanov,"

Phrase: "A.,"

Phrase: "Gorbunova,"

Phrase: "V.,"

Phrase: "Falcovitz,"

Phrase: "A.,"

Phrase: "Sigal,"

Phrase: "A.,"

Phrase: "Milyavsky,"

Phrase: "M."

Phrase: ","

Phrase: "Zurer,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Shohat,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Goldfinger,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Rotter,"

Phrase: "V."
Processing 00000000.tx.504: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.505: Change of the death pathway is senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. 

Phrase: "Change of the death pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "senescent human fibroblasts in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016030:Fibroblasts [Cell]

Phrase: "to DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "is"

Phrase: "caused by an inability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "p53."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]
Processing 00000000.tx.506: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.507: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: 21,1552 -1564.[Abstract/Free FullText] Shigenaga, M. 

Phrase: "21,"

Phrase: "1552 -1564."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shigenaga,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: K. and Ames, B. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ames,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.511: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.512: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.513: Assay for 8-hydroxy-2' deoxyguanosine: a biomarker of in vivo oxidative DNA damage. 

Phrase: "Assay for 8-hydroxy-2' deoxyguanosine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]
   716   C0050078:8-Hydroxy-2'-deoxyguanosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "a biomarker of in vivo oxidative DNA damage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0005516:Biomarker [Clinical Attribute]
Processing 00000000.tx.514: Free Radical Biol. 

Phrase: "Free Radical Biol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.515: Med. 

Phrase: "Med."
Processing 00000000.tx.516: 10,211 -216.[Medline] Suh., H., Lee, K. 

Phrase: "10,211 -216."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Suh.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.517: A., Kim, W. 

Phrase: "A.,"

Phrase: "Kim,"

Phrase: "W."
Processing 00000000.tx.518: H., Han, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.519: G., Vijg, J. and Park, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vijg,"

Phrase: "J."

Phrase: "and"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.520: C. 

Phrase: "C."
Processing 00000000.tx.521: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.522: Aging alters the apoptotic response to genotoxic stress. 

Phrase: "Aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the apoptotic response to genotoxic stress."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C1155291:response to genotoxic stress [Cell Function]
   820   C0149784:response to stress [Physiologic Function]
           response stress
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.523: Nat. 

Phrase: "Nat."
Processing 00000000.tx.524: Med. 

Phrase: "Med."
Processing 00000000.tx.525: 8, 3-4.[Medline] Sun, Y. and Oberley, L. 

Phrase: "8,"

Phrase: "3-4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y."

Phrase: "and"

Phrase: "Oberley,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.526: W. 

Phrase: "W."
Processing 00000000.tx.527: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.528: Redox regulation of transcriptional activators. 

Phrase: "Redox regulation of transcriptional activators."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1158770:Transcriptional Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.529: Free Radical Biol. 

Phrase: "Free Radical Biol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016693:Free radical [Biologically Active Substance,Chemical Viewed Structurally]
Processing 00000000.tx.530: Med. 

Phrase: "Med."
Processing 00000000.tx.531: 21,335 -348.[Medline] Takahashi, M., Dore, S., Ferris, C. 

Phrase: "21,335 -348."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Dore,"

Phrase: "S."

Phrase: ","

Phrase: "Ferris,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336852:ferris [Manufactured Object]

Phrase: "C."
Processing 00000000.tx.532: D., Tomita, T., Sawa, A., Wolosker, H., Borchelt, D. 

Phrase: "D."

Phrase: ","

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sawa,"

Phrase: "A.,"

Phrase: "Wolosker,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D."
Processing 00000000.tx.533: R., Iwatsubo, T., Kim, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: H., Thinakaran, G. et al. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thinakaran,"

Phrase: "G. et al."
Processing 00000000.tx.535: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.536: Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. 

Phrase: "Amyloid precursor proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   966   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   884   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "heme oxygenase activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1151460:haem oxygenase activity [Molecular Function]
   901   C1622683:oxygenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0018969:Haem Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "neurotoxicity in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.537: Neuron 28,461 -473.[Medline] Takeda, A., Smith, M. 

Phrase: "Neuron 28,461 -473."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neuron [Cell]
   741 E C0521390:Neuronal [Immunologic Factor]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Takeda,"

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: A., Avila, J., Nunomura, A., Siedlak, S. 

Phrase: "A.,"

Phrase: "Avila,"

Phrase: "J.,"

Phrase: "Nunomura,"

Phrase: "A.,"

Phrase: "Siedlak,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: L., Zhu, X., Perry, G. and Sayre, L. 

Phrase: "L., Zhu,"

Phrase: "X.,"

Phrase: "Perry,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sayre,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.540: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.541: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.542: In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. 

Phrase: "In Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "heme oxygenase"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
  1000   C0018969:Haem Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0018966:Haem [Biologically Active Substance,Organic Chemical]
   861   C0030065:Oxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1622683:oxygenase [Molecular Function]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   761 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   761 E C1511228:VESSEL, BLOOD [Tissue]
   750 E C1558950:VASCULAR [Finding]
   750 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "coincident with Alz50,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205420:Coincident [Temporal Concept]

Phrase: "an epitope of tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003316:Epitope [Immunologic Factor]

Phrase: "induced by 4-hydroxy-2-nonenal modification."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205263:Induced [Functional Concept]
   748   C0392747:Modification [Functional Concept]
   748   C0700307:Hydroxy [Inorganic Chemical]
   748   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.543: J. 

Phrase: "J."
Processing 00000000.tx.544: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.545: 75,1234 -1241.[Medline] Verhaegh, G. 

Phrase: "75,"

Phrase: "1234 -1241."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Verhaegh,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.546: W., Richard, M. 

Phrase: "W., Richard,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.547: J. and Hainaut, P. 

Phrase: "J."

Phrase: "and"

Phrase: "Hainaut,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.548: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.549: Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down regulates p53 DNA-binding activity by increasing the intracellular level of copper. 

Phrase: "Regulation of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulation [Governmental or Regulatory Activity]
   790   C1327622:Regulation [Biologic Function]

Phrase: "by metal ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "and by antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: ":"

Phrase: "dithiocarbamate"

Phrase: "down regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "p53 DNA-binding activity by increasing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2266866:Binding Activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   737   C0474395:increased activity [Finding]

Phrase: "the intracellular level of copper."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0373587:Copper level [Laboratory Procedure]
   797   C0428575:Copper level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.550: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.551: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.552: Biol. 

Phrase: "Biol."
Processing 00000000.tx.553: 17,5699 -5706.[Abstract] Weber, G. 

Phrase: "17,"

Phrase: "5699 -5706."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.554: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.555: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.556: Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle. 

Phrase: "Final common pathways in neurodegenerative diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
   750   C1511986:Disease Pathway [Conceptual Entity]

Phrase: ":"

Phrase: "regulatory role of the glutathione cycle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.557: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.558: Biobehav. 

Phrase: "Biobehav."
Processing 00000000.tx.559: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.560: 23,1079 -1086.[Medline] Related articles in JCS: Impaired p53 pathway in Alzheimer's JCS 2002 115: 1505. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "1079 -1086."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Related articles in JCS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "Impaired p53 pathway in Alzheimer's JCS 2002 115"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2984374:p53 pathway [Functional Concept]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: ":"

Phrase: "1505."
Processing 00000000.tx.561: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

